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Abstract 
 
 
Background: 
 
Pain mapping for specific disorders was described in the literature for face, back and hip 
pain, but not for shoulder pain. 
 
The aim of the study was to fill the gap in assessing patients as a whole for common 
shoulder disorders, to develop a pathway from subjective experience of patients to 
diagnoses of pathology, to ascertain specific patterns of pain in patients with common 
shoulder disorders, to describe comprehensive shoulder pain maps and to test these. 
 
Method:  
 
The study was designed in three phases with prospective blinded method. The first phase 
aimed to establish the pain patterns for common shoulder disorders. The patients, who 
presented as new patients with shoulder pain to the outpatient department, were given a 
custom-made shoulder mapping form to mark their pain, its character and severity. The 
patients’ final diagnoses were coded after investigations and the codes were correlated 
with the pain map patterns to achieve the aim. Later, colour-coded maps were established 
for each shoulder disorder. SPSS (statistic package) was used for the first study. 
 
The second phase was designed to test the accuracy of the previously established colour-
coded pain patterns in the first phase, to assess sensitivity and specificity of the maps for 
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the disease groups and each individual disorder, to improve the previous pain mappings 
and to establish an algorithm. This was achieved by collecting the maps from a larger 
number of the patients than the first phase’s number and the researcher, who was blind to 
the diagnoses, gave his estimations for each map immediately after collecting the maps 
from each patient. After all the investigations, treatments and follow-ups, the final 
diagnoses were coded.  
 
The final phase was to assess inter-tester reliability. The third phase was to test inter-tester 
reliability of the maps by estimating the shoulder diagnoses using algorithm and colour-
coded maps by three raters. This test was used to observe a score of how much consensus 
or homogeneity there was for the algorithm of the shoulder pain maps. Another aim in the 
third phase was to examine if the mapping system is easy to use or requires a lot of 
training.  
 
Statsdirect and VassarStats were used to analyse statistical data in the second and the third 
phases of the study.  
 
Ethical opinion was sought from the local R&D department and obtained. There was no 
conflict of interest. 
 
Results: 
 
The first phase of the study included 94 patients and showed that there were definite 
patterns for each shoulder disorder and it described colour-coded shoulder pain patterns 
according to the radiation of the pain around and beyond shoulder for six shoulder 
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disorders; acromioclavicular joint pathology, instability: Bankart’s, SLAP etc, calcific 
tendonitis, rotator cuff pathology, impingement syndrome, gleno-humeral joint arthritis. 
This showed a range from a very localised pain such as ACJ pathology to a very wide-
spread pain such as GHJ arthritis.   
 
The second phase of the study included 194 patients and it tested the mapping patterns 
from the first phase. The accuracy for the first estimation for individual disorders was 
45.4% and the overall accuracy for both estimations was 62.4. The sensitivity was high 
especially for instability and it was good for ACJ pathology and impingement syndrome. 
This phase clarified the pain patterns further and detailed three groups of pain patterns. 
The first group of diseases showed a localized pain around the shoulder and second group 
showed radiation of the pain beyond shoulder. Later, the second group was subdivided 
into two. Group 2A showed the pain radiation down to elbow level, whereas group 2B 
showed radiation below the elbow level.    
 
Third phase was to test inter-tester reliability of the maps by estimating the diagnoses 
derived from the maps by 3 raters. It tested the reliability for each disease group and 
individual disease.  It showed a substantial agreement between the raters (Kappa (κ)  = 
0.71) 
 
Conclusion: 
 
A definitive pattern of pain distribution and specific types of pain were demonstrated for 
common shoulder pathologies. Testing the established maps indicated that the colour-
coded maps were reliable and the algorithm was easy to understand.  The study advocates 
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the use of pain maps as an adjunctive diagnostic tool in general practice clinics and 
orthopaedic / shoulder clinics. 
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Introduction 
 
Shoulder pain is a common presenting complaint in orthopaedics and reaching a clear 
diagnosis requires many aspects of a patient’s assessment to be explored. There was a gap 
in the literature for assessing patients with common shoulder disorders as a whole and in 
developing a pathway from subjective experience of patients to diagnoses of pathology. 
Therefore, the current study endeavours to establish specific pain patterns for common 
shoulder disorders as an adjunct to the assessment of shoulder. Conditions causing 
shoulder pain are common and contribute substantially to the musculoskeletal morbidity of 
the community (Bjelle, 1989; Urwin et al., 1998). The prevalence of shoulder disorders 
has been reported to range from 7 to 36% of the general population (Lundberg, 1969) and 
it is the third most common cause of musculoskeletal consultation in primary care. 
Approximately 1% of adults consult a general practitioner with new shoulder pain 
annually (Mitchell, Adebajo, Hay, & Carr, 2005; Urwin et al., 1998). 
 
Pain mapping for specific disorders has been described for face, back and hip pain, but not 
for shoulder pain. Pain maps were found to be useful, for diagnostic, therapeutic, 
prognostic and research purposes. Although common pain patterns were described for the 
common shoulder disorders these are mainly anecdotal in the literature and no study 
specifically compared and mapped the common shoulder pain pathologies such as 
subacromial impingement, rotator cuff tears, glenohumeral joint (GHJ) arthritis and 
acromioclavicular joint (ACJ) pathology. Whilst shoulder diagnosis may involve a 
complex diagnostic process such as examination, specific tests, baseline x-ray, steroid 
injection, ultrasound, MRI scan etc., shoulder mapping could be an adjunction to this 
process.  
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The initial aim of this study was to ascertain specific patterns of pain in patients with 
common shoulder disorders and describe a comprehensive shoulder pain map as well as to 
develop colour coding for these patterns. Secondly, it was aimed to test accuracy of colour 
coding in the new patients’ clinic setting in correlation with the established pain mapping, 
to improve as needed and develop an algorithm. The objective was to be able to 
understand if they could have a clinical value in day-to-day practice.  The final part aimed 
to test reliability of the established pain mapping patterns and its algorithm. The objective 
was used to observe a score of how much consensus or homogeneity there was for the 
algorithm of the shoulder pain maps.  
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Nature of Literature Review 
 
Pain mapping for specific disorders was described in the literature for face, back and hip 
pain, but not for shoulder pain. 
 
The aim of the study was to fill the gap in assessing patients with shoulder problems as a 
whole, to develop a pathway from subjective experience of patients about their pain, pain 
types, radiation and severity of the pain to diagnosis of pathology, to ascertain specific 
patterns of pain in patients with common shoulder disorders, to describe comprehensive 
shoulder pain maps and to test these. 
 
Aim of the literature search 
 
The aims of the three phases in the current study were different. The literature search was 
designed to locate the studies for all three phases separately yet, more focused on mapping 
of shoulder pain in common shoulder disorders as the overall aim of the all three phases 
was to ascertain specific patterns of pain. Therefore, literature search aim to capture the 
studies related shoulder pain, diagnosis of the disease and pain mapping for the first phase 
as detailed below. For the second and third phase, the literature search aimed to review 
sensitivity and specificity, and reliability of mapping. The literature search for all the 
phases aimed to locate high quality reviews such as Cochrane reviews and in the absence 
of those, it aimed to locate any related publication to expand the search including Google 
Scholar. The aim of the current study was not to perform a systematic review and there 
were not enough studies in the literature to review on this subject. Nevertheless, the 
qualities of the relevant studies were checked using critical appraisal questions. 
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The aim of literature search for the first phase was to locate the studies about general 
shoulder problems, their diagnoses, investigations leading to diagnoses, and classifications 
of shoulder problems. By that way, this step aimed to decide if there was any need for pain 
mapping. In the next step, it aimed to locate previous studies on pain mapping, importance 
of it and existing literature. 
 
The aim in the second phase was to search the literature about testing the maps and to 
verify the clinical value and meaning of pain maps once the first phase was completed. In 
that context, it was to determine the accuracy of the pain mapping and its potential 
contribution to clinical practice. The literature search also aimed to locate similar studies 
showing sensitivity-specificity of the subjective experience of patients. 
   
The aim in the third phase was to search how reliable such a tool could be for diagnostic 
purpose by assessing inter-tester reliability and again to locate similar studies in the 
literature.  
 
Terms 
The main concepts searched in the first phase of the study were:  
1. concept: Shoulder  
2. concept: Pain 
3. concept: Disorder, Disease 
4. concept: Mapping 
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The set of terms were designed to capture all relevant literature related to shoulder pain 
mapping in the first phase using synonyms and thesaurus from Microsoft Word 
(Microsoft, 2010) and in addition, mapping and thesaurus, Medical Subject Headings 
(MeSH) from Medical Literature Analysis and Retrieval System Online (MEDLINE) via 
National Health Service (NHS) library (ProQuest, 2010;NHS Evidence, 2009). Also, the 
UK and US English spelling of the words were checked for full terminology. Additionally, 
this approach was discussed with a local hospital librarian to avoid any major omissions. 
In the next stage, a table of a list of terms has been prepared to use as a template to search 
all the databases (table-i in appendices). The other concepts such as sensitivity-specificity 
of pain maps and inter-tester reliability were searched separately. 
 
Databases Search 
 
In particular, the following databases were searched for relevant studies: 
Via the Cochrane library, systematic reviews and protocols have been searched. 
MEDLINE (from 1950 to 04/December/2013), Excerpta Medica dataBASE (EMBASE) 
(from 1980 to 04/December/2013) and Cumulative Index to Nursing and Allied Health 
Literature (CINAHL) (from 1981 to 04/December/2013) database have been searched via 
NHS library to find the studies of evidence-based medicine, clinical trials, case reports 
with literature reviews. Also, Google scholar was used and hand search was done in the 
local hospital libraries (which are not included in the appendix). The searches were not 
limited by study design or language of publication to maximise the sensitivity of the 
search.  No specific time limit was used. Duplicate results were removed from each 
individual database search results. The full strategies of shoulder pain mapping are shown 
in the appendix. 
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Diagnosis of Common Shoulder Disorders 
 
The population in the current study was the adult patients with shoulder pain, who 
presented to outpatient clinics as new patients. It can be a great challenge to diagnose the 
cause of shoulder pain due to the large number of aetiologies. The aetiologies are wide 
ranged and vary from a minor trauma, which can cause a sprain or a simple muscle strain, 
to a large tear of one of the shoulder stabilizer muscles. Some shoulder pathologies can 
lead to chronic pain and limitation in shoulder range of motion such as impingement 
syndrome, adhesive capsulitis, calcified tendonitis, cervical radiculopathy, glenohumeral 
osteoarthritis, and biceps tendonitis (Schwarzkopf, Oron, & Loebenberg, 2008). 
 
There are a large number of tools for diagnosis ranging from history and physical 
examination to a wide range of imaging modalities such as x-ray, ultrasound and magnetic 
resonance imaging (Schwarzkopf et al., 2008). Yet, owing to the complex anatomy of the 
shoulder and the spectrum of underlying disorders, the cause of pain can be still difficult 
to diagnose despite the improvement in imaging technology. Symptoms and medical 
imaging may not correlate well (Carter et al., 2012). 
 
The mixed or complex shoulder problems might cause difficulty in assessing the shoulder 
(however, there is no clear literature on how frequently multiple shoulder pathologies 
occur over the single ones). Dinnes, Loveman, McIntyre and Waugh (2003) stated that 
there are no clear national guidelines for the diagnosis of shoulder pain. Several diagnostic 
tests are used for the diagnosis of soft tissue disorders, including clinical assessment, plain 
x-rays, ultrasonography, magnetic resonance imaging (MRI), magnetic resonance 
arthrography (MRA) and arthroscopy, yet their relative accuracy, cost-effectiveness and 
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impact on quality of life are uncertain (Dinnes et al., 2003). The clinical assessment also 
includes collecting demographic information and assessment of the range of motion, 
specific physical signs, strength, and stability (Richards et al., 1994). 
 
Although the diagnosis of shoulder disorders should not be based on clinical examination 
alone, if performed with suggested standardisations, some of the tests are highly 
reproducible and therefore reliable to use in clinical practice (Johansson &  Ivarson, 2009; 
Guanche & Jones, 2003; Ure, Tiling, Kirchner, & Rixen, 1993). Neer impingement sign, 
Hawkins-Kennedy impingement test and Jobe supraspinatus test are well-described. The 
O'Brien's sign is helpful for diagnosing superior labral detachment (Tzannes & Murrell, 
2002).  The combination of the Hawkins-Kennedy impingement sign, the painful arc sign, 
and the infraspinatus muscle test yielded the best post-test probability up to 95% for any 
degree of impingement syndrome (Park, Yokota, Gill, El Rassi, & McFarland, 2005). 
Streoid injection is used for both diagnostic and treatment purpose in impingement 
syndrome (Fraser-Moodie, Shortt, & Robinson 2008). The current study included all the 
physical tests by experienced clinicians in the assessment of shoulder and injection 
especially for impingement syndrome and ACJ pathology as detailed in the method 
section. 
 
Shoulder pain associated with rotator cuff disorders and glenohumeral OA can be 
diagnosed in the majority of patients on the basis of medical history, focused physical 
examination, and plain film radiographs (Meislin, Sperling, & Stitik, 2005). They are 
specifically more helpful in diagnosing ACJ pathology and GHJ arthritis. Although plain 
radiographs can reveal degeneration of AC joint and GHJ arthritis, diagnosis cannot be 
based on this alone because similar radiographic findings can be seen in asymptomatic 
                                                                                                          Levent Bayam @00279526    
24 
 
individuals (Mall et al., 2013; Woodward & Best, 2000). In GHJ arthritis, an AP view of 
the glenohumeral joint will usually reveal degenerative changes and loss of joint space 
(Woodward & Best, 2000). Similarly, positive radiographs can be also helpful to diagnose 
calcific tendinitis (Burbank, Stevenson, Czarnecki, & Dorfman, 2008). Antero-posterior, 
axillary and supraspinatus outlet plain radiography views of the affected shoulder were part 
of our assessment for each patient.  
 
In Frozen shoulder, radiographs often appear normal as well as CT and MRI, although 
osteopenia of the humeral head may be noted as a result of disuse (Woodward & Best, 
2000). However, arthrography can establish the correct diagnosis of adhesive capsulitis in 
addition to clinical diagnosis (Brue et al., 2007; R. Neviaser & T. Neviaser, 1987). 
 
The further investigations to diagnose the shoulder disorders include ultrasound, MRI, 
arthrogram, and computed tomography (CT). Whereas the preferred test for diagnosing 
rotator cuff disorders is MRI (Dinnes et al., 2003), MRI arthrography has become the 
preferred test for the imaging of suspected labral pathology (Burbank et al., 2008; Van der 
Woude & Vanhoenacker, 2007). For full-thickness tears, overall sensitivities and 
specificities are high with MRI.  Where tear prevalence is relatively high, a negative 
magnetic resonance finding may be sufficient to rule out the presence of a full-thickness 
tear (Dinnes et al., 2003). Ultrasound was most accurate when used for the detection of 
full-thickness tears, although sensitivity was lower for detection of partial-thickness tear 
but specificity remained high (Dinnes et al., 2003). Therefore, it could be more cost-
effective in a specialist hospital setting for identification of full-thickness tears (Dinnes et 
al., 2003). In the current study, ultrasound, CT arthrogram, MRI and arthroscopic 
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procedures were part of decision process in diagnosing the shoulder disorders as explained 
in the method section. 
 
The common shoulder disorders included in the current study are impingement syndrome, 
adhesive capsulitis (frozen shoulder), calcified tendonitis, ACJ pathology, glenohumeral 
osteoarthritis, rotator cuff pathologies, and instability problems. In addition to their 
classification, the descriptions and the types of pain they can cause were discussed as 
below. 
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Classification of Common Shoulder Disorders and Their Descriptions  
 
There are a large variety of shoulder disorders and some classification systems to 
categorise these into different groups. Most shoulder problems fall into three major 
categories: soft tissue disorders, articular injury or instability, and arthritis (Dinnes, 
Loveman, McIntyre, & Waugh, 2003). One of the studies classified these into six 
diagnostic categories: capsular syndrome (adhesive capsulitis, arthrosis, frozen shoulder, 
etc.), acute bursitis, acromioclavicular syndrome, subacromial syndrome (chronic bursitis, 
tendinitis, rotator cuff tears), rest group, and mixed clinical picture (De Winter et al., 
1999), whilst another study described three different patterns of shoulder pain. These were 
Pattern 1: impingement pain, Pattern 2: acromioclavicular joint pain and Pattern 3: 
shoulder pain (frozen shoulder; glenohumeral osteoarthritis; complete cuff tear; 
subscapularis tear; painful laxity; post-traumatic instability; and internal derangement) 
(Carter et al., 2012). They all have some specific features as well as common 
characteristics. It is not always easy to diagnose these as they may not be an isolated 
problem but may be a rather a complex and mixed one.   
 
Subacromial impingement syndrome is a symptomatic diagnosis that may be the result of 
several patho-anatomical processes. Subacromial impingement syndrome can be described 
as the compression of the suprahumeral structures against the anteroinferior aspect of the 
acromion and coracoacromial ligament (Calis et al., 2000). It is suggested there is a multi-
factorial aetiology for this disorder. It includes inflammation of the bursa, degeneration or 
overuse of the rotator cuff tendons, weak or dysfunctional rotator cuff and/or scapula 
musculature, posterior capsular tightness, postural dysfunctions of the spinal column and 
bony or soft tissue anomalies (Limb & Hay, 2007). 
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Glenohumeral stability depends on several factors. These are competent capsulolabral 
structures, effective muscular activity, intact and effective neural connection and an 
absence of excessive extrinsic deforming force (Limb & Hay, 2007).  Deficiency of these 
will lead to instability. There is an association between instability and dislocation. 
Anterior shoulder dislocations typically occur when the arm is abducted and in external 
rotation.  Because the shoulder has an extensive range of movements (ROM), it is at risk 
for developing instability and is the most commonly dislocated joint in the body 
(Milewski, Hart, & Miller, 2012). Dislocation of the glenohumeral joint is the most 
common large joint dislocation with an incidence of 1-2 % (Limb & Hay, 2007).   A 
common reason of laxity is the labral injury. The SLAP lesion (superior labrum anterior 
and posterior) and other glenoid labral tears are common in throwing athletes who present 
with a painful shoulder that clicks or pops with motion (Woodward & Best, 2000). 
 
Calcific tendinitis of the shoulder is defined as a process involving calcium deposition 
commonly in the rotator cuff tendons. The disease is often chronic in nature and a cell-
mediated process. However it is usually self limiting in terms of its acute pain states (Hurt 
& Baker, 2003). 
 
Milewski et al. (2012) described that rotator cuff disease is a continuum beginning with 
mild impingement and progressing towards partial tear, full-thickness tear, and finally 
arthropathy of the rotator cuff. In younger patients, the rotator cuff injuries typically result 
from trauma whereas in the patients older than 40, chronic impingement syndrome often 
results in cuff tear (Woodward & Best, 2000). Diseases of the rotator cuff cover a 
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spectrum of disorders including tendinosis, tendonitis, tendinopathy and tears. Rotator cuff 
arthropathy is defined as a massive tear of the cuff. (Limb & Hay, 2007). 
 
Another common shoulder disorder is adhesive capsulitis, or frozen shoulder, which is a 
condition characterised by global restriction in the range of the glenohumeral joint (Limb 
& Hay, 2007). This pathology is defined as a self-limiting condition of unknown aetiology 
(Brue et al., 2007).  An autoimmune cause has been proposed (Woodward & Best, 2000).  
The diagnosis is mainly clinical and no significant changes are normally present at MRI or 
CT scan (Brue et al., 2007).  
 
Glenohumeral arthritis may develop following previous trauma, rotator cuff tear or from 
underlying causes such as rheumatoid arthritis, Lyme disease. Multiple joint involvement 
is suggestive of rheumatoid arthritis. Arthritis of the glenohumeral joint generally causes 
pain with activity, loss of passive motion and stiffness. Some patients may complain of 
night-time pain (Woodward & Best, 2000). 
 
AC joint problems can be divided two broad groups; AC joint disruption and osteoarthritis 
(OA) and/or osteolysis of the AC joint (Rull & Colin, 2013). Whilst AC joint disruption 
are seen very often as athletic injuries as a consequence of fall, direct blow or repetitive 
overhead motions, OA may occur after a trauma and more rarely as primary phenomenon. 
Distal clavicular osteolysis may occur spontaneously in rheumatoid arthritis, 
hyperparathyroidism, myeloma, systemic sclerosis, due to infection and in those who are 
involved in throwing sports/extensive upper limb weight training (Rull & Colin, 2013). 
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Osteoarthritis of the acromioclavicular (AC) joint is a common condition causing anterior 
or superior shoulder pain, especially with overhead and cross-body activities (Mall et al., 
2013). This most commonly occurs in middle-aged individuals because of degeneration to 
the fibrocartilaginous disk that cushions the articulations. Diagnosis relies on history, 
physical examination, imaging, and diagnostic local anesthetic injection (Mall et al., 
2013). The patients with all the above disorders present to the clinics with shoulder pain, 
which requires further assessment. 
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Importance of Mapping to inform diagnosis 
 
The pain was described as an experience that was perceived by the patient (Pain 
management, 2014). Another definition was “an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of such 
damage" by International Association for the Study of Pain (IASP) (International 
Association, 2012). Pain is the most common symptom in musculoskeletal medicine and is 
described using a variety of terms. Clear differences exist between the “throbbing” pain of 
an abscess, “aching” pain of chronic arthritis, “burning pain” of neuralgia and the 
“stabbing pain” of a ruptured tendon. The precise location of pain is important in 
orthopaedics but does not always correlate with the site of pathology (Rodowsky & 
Bigliani, 1997). In the spine, pain signals are generated from nerve roots and travel neural 
pathways through the body. When nerve roots are compressed, they generate pain signals 
that can be felt in different areas throughout the body (North American Spine, 2013). 
However, pain arising in or near the skin is usually localised accurately, as is pain from 
intrinsic shoulder pathology (Rodowsky & Bigliani, 1997) whilst pain arising in deeper 
structures is more diffuse and sometimes has an unexpected distribution (Apley & 
Solomon, 1993). One explanation for this in the shoulder is due to its proximal location in 
the “sclerotome” and the extensive convergence of afferent signals from this region to the 
dorsal horn of the spinal cord. The “sclerotome” is defined as pain arising within the 
periosteum and muscle innervated by one spinal segment (Inman & Saunders, 1944). 
. 
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In the literature, there were limited studies, which attempted to specify the pain patterns 
for shoulder disorders. One of the studies explained that pain patterns can be broadly 
distributed to the deltoid, trapezius, and posterior scapular region. The location of 
symptoms may or may not correspond to the proximity of the pain generator (Sizer-
Phillip, Phelps, & Gilbert, 2003). Cervical disc disease commonly presents with pain 
referred to the shoulder. This pain is most often referred to the posterior aspect of shoulder 
and trapezius and occasionally to forearm or hand (Rodowsky & Bigliani, 1997). Other 
examples of referred pain involving the shoulder include the stimulation of the 
diaphragmatic tendon centre that typically produces shoulder pain (Di Massa, Avella, & 
Gentili, 1996). 
 
Similarly, shoulder pain with radiation to the arm and hand in an ulnar nerve distribution 
could be an indicator to the existence of a Pancoast tumour (Kovach & Huslig, 1984). Pain 
from the sternoclavicular joint can be referred pain to areas distant from the joint (Hassett 
& Barnsley, 2001).  
 
Many different shoulder disorders cause similar symptoms and patterns of pain (Larson, 
O`Connor, & Nirschl, 1996). The pain related to rotator cuff pathology is described as 
insidious onset exacerbated by overhead activities and it is in the deltoid region 
(Rodowsky & Bigliani, 1997). Arthritis of the glenohumeral joint generally causes pain 
with activity and frozen shoulder classically consists of shoulder pain that is slow in onset 
(Woodward & Best, 2000).   
 
Gerber, Galantay and Hersche (1998) aimed to ascertain the distribution of ACJ and 
subacromial impingement pain by injecting hypertonic saline into the ACJ and 
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subacromial spaces of normal subjects. There was a description of pain distribution for 
calcific tendinitis from the point of the shoulder to the deltoid insertion commonly and, 
less frequently, to the neck (Woodward, 2013), 
 
Subacromial irritation in Gerber’s paper resulted in an “intense” pain mainly in the lateral 
border of the acromion and the lateral portion of the deltoid muscle (Gerber et al., 1998). 
Dutton (2008) described that the pain that radiates beyond the elbow is far less likely to be 
due to shoulder pathology, particularly if it is associated with any sensory disturbance in 
the limb such as distal radiation or pain, numbness or paresthesia (Dutton, 2008). 
Similarly, Woodward and Best (2000) concluded that the pain related to impingement 
usually occurs over the anterolateral aspect of the shoulder, often with some radiation to, 
but not usually beyond, the elbow. 
 
The patient’s experience of the pain is the key many times. It is widely taught that 
diagnosis is revealed in the patient's history and even the history alone may display the 
diagnosis. Sometimes it is all that is required to make the diagnosis (Rull & Draper, 2011). 
Pain mapping is illustration of patients’ statement of their subjective complaints and 
possibly a part of history taking. Therefore, a well-designed visual pain map may guide 
patients to express their symptoms in a more descriptive way and in return, this may help 
doctors for diagnoses.  
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Existing Literature in Pain Mapping  
 
 
Modern pain mapping was introduced in 1949, when Palmer (1949) provided outline 
diagrams of the human body and asked patients to mark on the charts wherever they 
experienced pain. The usage of pain maps in clinical practice is now more widespread and 
forms part of the McGill pain questionnaire (Rankine, Fortune, Hutchinson, Hughes, & 
Main, 1998). When Rankie et al (1998) assessed the ability of the pain drawing to predict 
the presence of nerve root compression, there was considerable overlap in the appearances 
of the pain drawings between patients with and without nerve compression. They 
concluded that pain drawing should be interpreted with caution and in light of the full 
clinical picture. Accordingly, our approach to pain mapping was to examine if the pain 
mapping can be used as adjunct to the full assessment in shoulder disorders’ diagnoses on 
oppose to using as sole diagnostic tool. 
 
Patients can complete the self-evaluation portion of the questionnaire in the absence of a 
physician. A shoulder score may involve the visual analogue scale score for pain and the 
cumulative activities of daily living score (Richards et al., 1994).  The questionnaire 
approach may give a fairly good picture of the neck/upper extremity status (Ohlsson, 
Attewell, Johnsson, Ahlm, & Skerfving, 1994). The primary types of self-reported 
measures of pain include the verbal rating scales (VRS), numerical rating scales (NRS), 
visual analogue scales (VAS) and pain drawings (PD). Each of these methods has 
advantages and disadvantages (Disorbio & Bruns, 1999). Despite the simplicity, a number 
of persons had difficulty using them however; the VAS and NRS scales are more easily 
comparable. The article showed different aspect of the pain scales and suggested that there 
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may be an identifiable pattern of specific pain ratings that are consistent for each medical 
diagnosis. The paper’s review on VAS and suggestions were relevant to our approach of 
specific pain patterns for each shoulder disorder as well as the choice of additional use of 
VAS in our custom-made shoulder mapping form. 
 
The pain mapping has been described for neck, face, back and hip pain. Different projects 
of using pain maps are suggested. One of them is to provide markers for the location of 
pain in the human brain (Medicalxpress, 2012). It is also suggested that pain map could be 
used to determine the kinds of pain which are felt by patients who are unable to articulate 
it. This could be facilitated using functional magnetic resonance imaging (fMRI). The 
study named the pattern, which is obtained following a charted blood flows through the 
brain, as the signature of brain activity (Pain Signature, 2013). Another project is three-
dimensional pain mapping using a computer method, which allows patients to mark the 
location, intensity, and depth of pain on a three-dimensional model of the human body 
(Baird, 2009). The model can be rotated to obtain better viewpoints for marking pain. 
 
No other study was found in the literature to test shoulder pain mapping as the current one 
was the first study. Among the limited literature, one study was by Pang et al. (1998) on 
analysis of spinal pain mapping. The authors tried to find the source of pain and map the 
pain related to back pain after all the investigations. The study was not a blinded study 
with potential bias. The level of the evidence for this study was four.  It concluded that 
spinal pain mapping is a functional approach to the diagnosis. However, it was performed 
in conjunction with nerve block and it was to analyse the source of pain including the 
other investigations including CT, MRI and EMG.  The study by Turp et al. (1998) was 
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about pain maps from patient with persistent facial pain. The aim was to look the facial 
pain radiation and how the pain distribution was related to the dermatomes. The study was 
a prospective and primary cohort study. The design was appropriate for diagnostic purpose 
but there was not any explanation about ethical implications. The level of evidence was 4 
for this research. 
 
The second and third phases of the study were related to sensitivity and specificity of a 
clinical measurement. Sensitivity shows the proportion of the patients with the disease, 
whose tests are positive and specificity shows the probability that the patients does not 
have the disease when they are disease free (Faragher, 2005). In the literature, there were 
no other studies on the sensitivity and specificity of patients’ subjective assessments in 
diagnosing the shoulder diseases.  
 
The aim of the third phase in the current study was to test inter-tester reliability which 
helps to understand the consistency of the raters estimates (Cherry, 2013). This test was 
used to observe a score of how much consensus or homogeneity of algorithm of the 
shoulder pain mapping. In the literature search, most of the relevant intertester reliability 
studies were on spinal pain and there was one study on shoulder pain. The aim of the study 
by Carter et al.(2010) was to describe and determine the inter-tester reliability of a newly 
developed classification system of shoulder syndrome recognition with inter-tester 
reliability on 255 patients. It was designed as a blinded study and the kappa coefficient 
was 0.664. One of the spine studies had an aim to determine the inter-tester reliability of a 
low back pain classification system among experienced and novice clinicians. This was a 
prospective cohort study and included 204 patients. The kappa coefficient was 0.61. Those 
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studies help us in designing the third phase of the current study however, those two studies 
were not related directly to pain mapping.  
 
Literature search did not locate another study on shoulder pain mapping for common 
shoulder disorders and it did not reveal any other study for sensitivity-specificity of pain 
mapping and inter-tester reliability. 
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Identification of Necessity for this study 
 
  
The literature search showed no previous study on pain mapping for shoulder disorders. 
There was a gap in the literature in assessing patients with shoulder problems as a whole 
from the patients’ subjective description to diagnosis of pathology in their shoulder. 
 
The experience and observation of the authors in the first phase of the study led to believe 
that there is a definite pain pattern for the shoulder disorders and the literature showed that 
pain mapping as a tool is good way of assessing the pain and VAS is a useful tool for the 
pain severity. (Disorbio & Bruns, 1999 ; Rankine et al., 1998). Therefore, custom-made 
shoulder mapping was designed for the current study (figure I).   
 
This study potentially would help us to understand the pattern recognition in shoulder pain 
and direct the examiner for use of specific test to support the diagnostic hypothesis 
generated by maps / patterns. Although it would not be enough to establish the accurate 
diagnoses in the absence of other clinical assessment tools but may strongly suggest the 
one. This could be similar to the example that O’brien test is used in diagnosis of both 
SLAP lesion of shoulder instability and ACJ pathology but more pathognomonic for ACJ 
pathology. Similarly, the shoulder pain mapping may show a pattern which may fit to two 
different diagnosis but could fit one diagnosis more than another one.   
 
This study aimed to fill this gap with a visual questionnaire, which was easy to understand 
and mark. This was probably to aid the diagnosis as an adjunct to the other assessments. 
Should the study show the definite patterns, testing these would help strengthen the aims 
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of the study. Therefore, the second and third phase of the study was planned to test the 
established shoulder pain patterns via blind estimation of the diagnoses and inter-tester 
reliability by researcher and other raters.     
 
In summary, the aim of the current study was to ascertain specific patterns of pain in 
patients with common shoulder disorders, describe a comprehensive shoulder pain map 
and to test their reliability. 
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Method 
 
Pain mapping for specific disorders was described in the literature for face, back and hip 
pain, but not for shoulder pain. Literature search revealed a gap on this area. The aim of 
the study was to fill the gap in assessing patients as a whole for common shoulder 
disorders, to develop a pathway from a subjective experience of patients to diagnosis of 
the pathology, to ascertain specific patterns of pain in patients with common shoulder 
disorders, to describe comprehensive shoulder pain maps and to test these. This aim of the 
method section was to detect which methodology and approach to be used in order to 
achieve the aims.  
 
It was planned as a prospective blinded study, which was conducted in three phases. Each 
phase had some differences in terms of their methodological approach. Therefore, this 
section was divided into three parts and each phase of the study was explicated separately 
in details. Each part included the following headings: method, design, participants, 
recruitment, procedure, data analysis, ethical implications. 
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Phase One  
 
The first phase was to establish pain patterns for common shoulder disorders. The aim was 
achieved by collecting custom-made pain maps (which was explained in details as below) 
from the patients, who presented to the shoulder outpatient clinics as new patients and by 
comparing them with their final diagnoses. The details of the first phase were explained in 
method, design, participants, recruitment, procedure, data analysis, ethical implications 
sections. 
 
 
Method:  
 
The method for the first phase of the study was planned as prospective and blinded one. A 
prospective study usually involves taking a cohort of subjects and watching them over a 
long period. Comparing to retrospective studies, however, prospective ones generally have 
fewer potential sources of bias and confounding factors.  Most sources of error are due to 
confounding factors and bias is more common in retrospective studies than in prospective 
studies (StatsDirect, 2013). 
. 
Blinding is another key factor in studies in terms of their bias. Hróbjartsson et al. (2013) 
explained that non-blinded outcome assessments were very common in orthopedic 
traumatology and they tended to generate substantially biased effect. In some trials, 
conscientious non-blinded assessors may overcompensate for an expected bias in favour of 
the experimental intervention and paradoxically induce a bias favouring the control, 
whereas other trials would have fairly neutral assessors with no important bias 
(Hróbjartsson et al., 2013). Blinding of the researcher to the diagnoses in the current study 
might have an important role to prevent the bias about their estimations. 
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The study aimed to perform a quantitative study about shoulder pain mapping. However, 
the pain can be subjective and the reception of the pain may vary from patient to patient. 
An addition of qualitative assessment to the study about pain perception of the patients 
would increase the strength of the study and potentially give a better picture of patients’ 
experience and pain patterns. However, this will probably mean further extension of the 
study and this could be beyond the scope the current study. 
 
Design:  
 
This was the first phase of the three-phase study. The phase one aimed to ascertain definite 
pain patterns of common shoulder disorders via a shoulder pain radiation form, which was 
a custom-made pain map (as explained below) showing pain localisation, type of pain and 
severity and collected from each patient (Figure I).  Then, the maps were correlated with 
the final diagnoses which were coded after all the investigations. 
 
The custom-made shoulder map was developed to simplify the appearance of the shoulder 
with the pain types and also visual analogue scale (VAS) was added for the severity of the 
pain so that the patients would understand without detailed explanation in the outpatient 
setting (figure I). in the end,  custom-made upper limb pain map was a shoulder pain 
radiation form, which was used in the study illustrated the type of pain, its severity and 
area/s of radiation. The pain map showed the anterior and posterior part of the whole arm 
including the neck and shoulder. Each side of the arm was divided into 14 sections or cells 
giving a total of 28 cells. The acromio-clavicular joint and axilla regions were included 
amongst the cells. A choice of 4 different pain types, each with an associated symbol were 
given to the patients to illustrate their pain on the pain map; + indicated a sharp, stabbing 
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or shooting pain, o for burning pain, • (dot) indicated a dull or aching pain and Δ for 
numbness and pins & needles. For analysis, the abbreviations; S, B, D, P were used 
respectively (figure I). 
 
Severity of the pain was assessed using a visual analogue scale (VAS), which was added 
to the custom-made upper limb pain map (figure I). Patients rated the intensity of pain on a 
continuum of no pain to the maximal worst pain imaginable. The VAS score is the 
distance from the lowest pain level to the mark made by the patient (Jensen & Karoly, 
1991). 
 
Several studies used pain mapping and VAS questionnaire. For example Rankine et al 
(1998) used pain drawing in a prospective study and they compared the pain drawings 
results with MR lumbar spine magnetic resonance imaging. In the current study, we 
conducted a prospective study similarly, and we compared the pain mapping with final 
diagnosis including Ultrasound, x-rays, MR,and clinical assessment. We used multiple 
tools for final diagnoses as some shoulder disorders can be difficult to diagnose and only 
MR scan would not be enough for full diagnoses with false negative rates (Dinnes et al., 
2003). 
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Figure I: The sample map to be marked by the patients (excluding the red and  
    green marks: they were only used on comparison sheet)  
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Participants:  
 
The participants were to be adults (16 years and over) with shoulder pain and the inclusion 
and exclusion criteria as below.  
 
Inclusion Criteria: The patients, who were adult (16 years old and over), presented to the 
shoulder clinic of a university hospital as new patients with shoulder pain but without any 
previous intervention or previous treatment were included to the study.  
The patients in the current study were selected from the new patients because if any 
previous treatment was undertaken for these patients, their pain patterns could be changed 
due to the treatment.  
We did not aim an age limit as different shoulder disorders may present in different ages. 
The shoulder clinic of the hospital in its nature was designed to see all the adults with 
shoulder problems. It did not include the population under the age of 16.  
 
Exclusion Criteria: The patients with symptoms of neck pain, clinical features indicating 
neck pathology such as disc disease, spinal cord compression, or previous and multiple 
shoulder problems, ipsilateral other upper limb problems were excluded from the study. 
Additionally, any patients with suspicion of carpal / cubital tunnel syndrome or nerve 
compression were also excluded from the study as some shoulder pain may present with 
numbness or pins and needles. After initial exclusion, if the patients had no complete 
diagnosis, or diagnosed later with neck, multiple shoulder problems and carpal / cubital 
tunnel and if the patients marked the shoulder maps inappropriately (such as wrong 
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marking signs, outside the area or no marking at all etc.), they were excluded as well at a 
later stage, as shown in results section. 
 
Recruitment:  
 
The patients, who presented as new patient with shoulder pain, were recruited from the 
outpatient clinical of a university (teaching) hospital. The patients gave their verbal 
consent to mark the localisation their pain, type of the pain and the severity on the map. 
The recruitment was specifically from the new patients to avoid any mixed picture of the 
shoulder problem as the previous treatment could mask the pain’s character.  
 
Procedure:  
 
 
All the patients were given a full explanation as to the nature of the study and they gave 
informed consent to participate at this stage. They were asked to demonstrate and mark 
their pain type, localisation and severity on the custom-made shoulder pain map. All the 
maps were coded with a final diagnosis after all the investigations as detailed below. The 
pain maps with multiple diagnoses or any doubt in diagnosis were excluded. 
 
The specialised clinicians’ opinions, who were either upper limb orthopedic surgeon or 
senior upper limb physiotherapist and who were blinded to the map, were sought for 
diagnosis. In conjunction with the other investigations, the definite diagnoses were coded 
to the questionnaire form once all those assessments were completed for each individual 
patient. It was a definitive end point diagnosis after combination of all the above 
procedure.  The first phase part of the current study was to establish a specific pattern of 
pain for each common shoulder disorder. 
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All patients completed an upper limb pain map prior to their consultation with the 
clinician. Patients were given clear verbal explanations on the map about how to complete 
it. The ones who agreed to complete the map were included to the study. 
 
In outpatient clinical setting, all the patients were assessed with a detailed history, 
examination and specific shoulder tests (Apprehension, Hawkin’s, Gerber etc.). 
Radiographic assessments and ultrasound scans were performed as part of the setting in 
the outpatient clinic. Whilst radiographs included antero-posterior, axillary and 
supraspinatus outlet views of the affected shoulder, ultrasound scans were carried out 
vastly on the patients with suspicion of rotator cuff tears, impingement and calcific 
tendinitis. Some patients had MRI scan, MR arthrogram and / or arthroscopy at a later date 
before confirming their diagnosis. Local diagnostic injections were also performed in a 
number of cases especially when clinical diagnosis suggested ACJ pathology, 
impingement and calcific tendinitis. The figures about the injection and further 
investigation were added to the result section. There were 94 patients included to the first 
phase of the study. 
 
Data collection 
 
 
There were six groups included to the study in the first phase. Collecting the data 
clinically to get enough numbers for a clinical study is always a difficult task and time 
taking process especially when the clinicians change their work place very often. 
Therefore, the number of patients for some groups was limited.  
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The patient data included all the assessments of the patients from the first presentation to 
the treatment in the first phase. Data can be collected through the application of techniques 
such as interviews, questionnaires, observation, direct physical measurement, and the use 
of standardised tests (Polgar & Thomas, 1991). The role of chance can be minimised by 
designing a study with adequate sample size and precision to assure a low Type 1 error 
rate (Newman, Browner, & Hulley, 2001). In the current study, the mapping forms were 
collected through pain questionnaire forms during their clinical assessment in outpatient 
clinical setting. Additionally, the data about their diagnosis were obtained through the 
electronic patient data from the clinical letters, investigations and operation notes. The 
next step was to code the diagnoses to the maps. 
 
The examining clinicians were blinded to the pain map result. In conjunction with the 
other investigations, two separate clinicians’ opinions were sought for diagnosis in order 
to help increasing the precision of diagnoses. The definite diagnoses were not coded to the 
questionnaire form by the researcher until all those assessments completed for each 
individual patient. 
 
Data analysis (and analytic strategy):  
 
 
The final diagnoses were correlated with the results of the pain maps. Cells on the 
shoulder pain radiation form were considered positive when the appropriate symbols had 
been marked. The distribution of the pain was manually correlated with the clinical 
diagnosis to ascertain a relationship between site of pain and the particular shoulder 
pathology.             
                                                                                                          Levent Bayam @00279526    
48 
 
 
           
The data from the custom-made upper limb pain map and the additional data of clinical 
assessment about the diagnoses were collected and converted to a data sheet (excel) for 
analysis. Then, the data sheets were transferred to statistical packages as required.  
 
The map patterns were established by using the excel sheets for each diagnosis.  Each side 
of the arm was divided into 14 sections or cells giving a total of 28 cells. On excel, each 
cell was assessed for each individual diagnosis. The number of the cells, concentration of 
each pain type in the cell and localisation were assessed as a group map for each diagnosis 
and compared with the other diagnoses by means of excel sheets and summary tables. 
Then the pattern for each disorder was established and the differences were evaluated.  
 
One part of the process was to establish colour-coded pain patterns, which meant to 
facilitate easier understanding of different pain patterns for each shoulder disorder. During 
the process of submission of the first phase for publication, one reviewer suggested to 
code pain patterns and to reflect each type of the pain with different colours so that the 
complex pain patterns on the tables would be distinguished better and would add 
simplicity to recognition. Therefore, a colour-coded shoulder pain patterns was established 
for each shoulder diagnosis and this included the pain type and distribution on the upper 
limb. The final patterns representing each disorder of the upper limb were mapped 
anteriorly and posteriorly.  
 
However, there were other possible options of establishing these maps. One of them could 
be a statistical approach to correlate the diagnoses with each cell, pain type or distribution.  
Nevertheless, due to high number of the cells and the pain types as well as the varieties in 
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patients’ descriptions of the pain on the map, it looked very complex and needed more 
patients in each group. In addition, the opinion from a local statistician supported this 
view. Therefore, statistics was not used to establish pain mapping patterns. Yet, the 
number of cells marked (distribution of the pain) by the patients and severity of the pain 
were able to be tested statistically.  
 
The number of the groups and the number of the patients in each group were not known 
initially and this was not predicted or calculated prior to the study as the researcher was 
blind to diagnoses. The final diagnoses were obtained at the end of phase one and the 
number of the groups and the number of the patients in each group were determined at this 
stage. Therefore, sample size was not calculated prior to the study. But post-hoc 
calculations were performed for the results with statistically significant findings. 
     
As the number of the area, severity and type of pain were quantified, the study type was a 
quantitative study and the data was parametric with more than two groups in the study. 
Statistical analysis was conducted using SPSS (Statistical Package for the Social Sciences) 
16.0 version for Windows included P-P plot to determine if the sample is normally 
distributed and Pearson’s correlation tests to see any correlation between the number of the 
area and the severity of pain in the first step of the study. On assumption of normal 
distribution, one-way ANOVA (the analysis of variance) was used. 
The decision on choosing the test (ANOVA) is based on one independent variable and 
multiple dependent variables. It is not appropriate to treat each pair-wise testing as a single 
test when there are multiple of them, using the conventional 5% level of the significance 
(Anthony, 1999). The solution of revised α value for multiple comparison is to use 
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ANOVA for parametric data instead of t-test. The important items to note are the F value 
and its significance. The F value increases as the groups differ more (Anthony, 1999).  
 
However, the rest of the data such as pain patterns, which was not comparable statistically 
due to high number of varieties (several diagnoses with several types of pain) and 
comparatively low number of patients, was analysed over excel sheet as “hand 
comparison” and the general patterns of pain character and distributions for common 
shoulder disorders were established.   
 
One-way ANOVA was used to find a meaningful difference in the number of areas 
marked by the patients. The VAS scores were analysed to see if there is any significant 
difference in the range of pain between the diagnoses. Opinion was sought from the local 
statistician for statistical analysis.  
 
Upon completion of first phase of the study, the colour-coded shoulder pain maps for 
common shoulder disorders were achieved.  
 
 
Ethical implications 
 
The current study was conducted in the outpatient clinic setting by providing a map to the 
patients to mark their pain type, distribution and the severity. The patients presented to the 
hospital with a new shoulder problem and there was not any intervention by means of an 
additional investigation or a treatment for the purpose of the current study. National 
Research Ethics Service (NRES) advises to seek opinion from research and development 
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(R&D) office clinical governance office in the first instance (Health Research, 2013). 
Ethical opinion was sought from local R&D department. The local R&D department gave 
their opinion saying that ethical approval is not needed for this study as all the 
investigations and the treatments included in the study were already part of their routine 
clinical assessment, and there was not any additional investigation or intervention related 
to the current study.  
 
The other areas, which might cause potential problems or dilemma, are anonymity of data, 
public availability, and possible future prospective studies, which the current study could 
lead to. Regular revision may be required to avoid breaching ethical limits at any stage. 
 
The data of the current study was anonymised by giving a number to each patient and 
matching identifications of patients in a different file, which was held in a separate 
document folder. To further enhance security, the memory device, which was used for the 
anonymised data of the study, was encrypted. 
 
Conflict of interest is another ethical issue for a study. Participants in peer review and 
publication should disclose their conflicting interests, and the information should be made 
available, so others can judge their effects for themselves (International Committee, 1993). 
There was no conflict of interest for the current study and participants had no financial 
interest in any product or service related to phase one the study. 
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In summary- Phase one 
Population: Adult patients (16 years and over), presented as a new patient with 
shoulder pain. 
Intervention: There was no intervention related to the study. The investigations in 
outpatient clinic were part of routine patient assessments 
Comparison:  Pain patterns and common shoulder disorders 
Outcome measures: To ascertain specific patterns of pain in patients with common 
shoulder disorders, to establish an algorithm to facilitate the use of maps in practice  
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Phase Two 
 
The aim of the second phase to test the color-coded pain patterns which were established 
during the first phase of study, to analyse their accuracy, sensitivity-specificity, to improve 
them if required and to establish an algorithm. The clinical setting was the same as the first 
phase but hospitals and the sequence of the procedures were different. The aim of this 
phase was achieved with another prospective study with a larger group of new patients, 
who marked the localisation of their pain, type of their pain and severity on the same 
custom-made shoulder pain map and the researcher estimated the diagnoses of shoulder 
problem only using the established colour-coded pain maps from the first phase of the 
study.  
 
Methods:  
 
This was a prospective study as it was done in the same manner as the first phase but with 
a new group of patients. The researcher was blinded to the diagnoses when he estimated 
the diagnoses of the shoulder disorder. The researcher coded the provisional diagnoses 
immediately after each patient handed their pain maps.   
 
Design:  
 
In the second phase of the study, as in the first phase, the patients, who presented to the 
shoulder outpatient clinics, marked their pain localisation, type and severity on the same 
custom-made maps. Different to the first phase, the second phase aimed a larger group of 
patients to increase sample size for each disease group, for better analysis and statistical 
evaluation and the researcher gave two estimations of diagnoses for each map immediately 
after collecting from the patients. The researcher used only previously established colour-
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coded maps for the estimation without any further information about patients’ history, 
clinical assessment and treatment.  
 
The final diagnoses of the shoulder disorders were coded as explained in the below 
procedure section, in similar way to the first phase and the estimation and diagnoses were 
correlated to detect the accuracy of the estimation, sensitivity-specificity  
 
 
Participants:  
 
The participants were adult (over 16 years old) patients with shoulder pain included to the 
study with the same inclusion and exclusion criteria; the same as it was in the first phase 
of the study. 
 
 
Recruitment:  
 
The patients, who presented as new patients with shoulder pain, were recruited from 
shoulder outpatient clinics of two different hospitals; a large and sub-specialised 
orthopaedic hospital and a private hospital. The patients, who were involved in the study, 
were given a map showing the front and the back of the shoulder and the pain types (figure 
I). They were asked to mark the pain type, distribution and the severity of the pain before 
their clinical assessment. 194 patients were included to the second phase of the study. 
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Procedure:  
 
The patients were asked to demonstrate and mark their pain and severity on the map and 
they gave informed consent to participate as it was in the first phase of the study. The 
collection of the maps in the second study lasted 10 months (January 2010-October 2010). 
As soon as the shoulder pain radiation maps were collected from the patients, two 
estimations of diagnoses were coded by the researcher, who was blind to the diagnoses, 
and used the previously established colour-coded shoulder pain maps in the first phase in 
order to test their accuracy. They were coded immediately after they were marked by the 
patients and before any further data was obtained about the patients. The reason of coding 
the maps with two estimations was some similarities in the pain patterns of different 
shoulder disorders. The shoulder maps were anonymized, filed and kept separately with 
numbers from 1 to 194.    
 
The second phase of the study was planned to leave longer period before collecting data 
about the final diagnosis of each patient. By this way, more accurate diagnoses would be 
able to be obtained. At the end of the long periods (at least12 months, November 2011 to 
start data collection), all patients had their investigations completed as well as their 
treatment including operations and follow-ups. Besides, the other aim of this phase was to 
improve previous colour-coded diagnostic figures and to contribute to the results from the 
first phase. The data about their diagnosis were obtained through the electronic patient 
data from the clinical letters, investigations and operation notes.  
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Data analysis: 
 
Once the final diagnoses were obtained, these were coded to the maps. The diagnoses’ 
codes were correlated with the estimation codes to test the accuracy of the established pain 
maps for each diagnosis. Then, the two phases were combined to conclude the final 
patterns for each shoulder disorder.  
 
The excel sheet is transferred to the package for analysis and reports as it was in the first 
phase.  The second study was analysed using VassarStats (Lowry, 2013) and 
Statsdirect(2013) . and again. Initially, sensitivity and specificity (of 2 groups and) for 
each diagnoses were checked with VassarStats. The aim of the second phase was to test 
the previously established pain mapping and to find out how well the estimations agree 
with the diagnoses. Sensitivity, specificity, and predictive values are used to give the value 
of the clinical decision tool (Harris & Taylor, 2008) (please refer to statistical 
terminology). Confidence interval was used to exclude the trivial estimation. Sensitivity 
and specificity of the disease groups and also for each individual disorder were described. 
For this purpose, VassarStats was used (Lowry, 2013) and StatsDirect (2013) package was 
used for analysis of the other data such as age, agreement between estimation and 
diagnoses, agreement between map group and disease group. Opinion was sought from the 
local statistician for statistical analysis as it was done in the phase of the study.  
 
An algorithm was aimed to produce at the end of this phase in addition to the 
improvement in the patterns of pain maps. Furthermore, a how-to-read the shoulder maps 
guidelines was planned to add to conduct the third phase of the study, inter-tester 
reliability.  
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Ethical Implications:  
  
 
The setting of the study and participants were as in the first study, only the hospitals were 
different. Ethical opinion was sought from local R&D department and obtained. 
 
The data of the second phase was anonymised by giving a number to each patient and 
matching identifications of patients in a different file, which was held in a separate 
document folder. The memory device, which was used for the anonymised data of the 
study, was encrypted 
 
There was no conflict of interest for the second phase and participants had no financial 
interest in any product or service related to phase two the study. 
 
In summary-  Phase two 
Population: Adult patients (16 years and over), presented as a new patient with 
shoulder pain. 
Intervention: There was no intervention related to the study. All the investigations, 
treatments and follow-ups were part of patient care for their shoulder problems. 
Comparison:  The researcher’s estimations of diagnoses with the established 
colour-coded shoulder pain patterns 
Outcome measures: To measure the accuracy, sensitivity-specificity of the 
previously established colour-coded shoulder pain maps and to establish an 
algorithm to establish an algorithm to facilitate the use of maps in clinical practice. 
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Phase Three 
 
The aim of the third phase was to test intertester-reliability of the shoulder pain maps. This 
was achieved by three experience clinician as raters / testers, who were blind to the 
diagnoses, coding their two estimations of diagnoses for each pain map and using the 
algorithm and colour-coded shoulder pain patterns from the second phase of the study. 
Another aim in the third phase was to examine if the mapping system is easy to use or 
requires a lot of training. The testers’ estimations were tested with Kappa values for their 
agreements.  
 
Method:  
 
It was conducted with a blinding method; the three testers were blind to the diagnoses. 
They were given algorithm, colour-coded maps for shoulder pain diagnoses. They were 
asked to code their two estimations on separate forms for each patient.  
 
Design:  
 
 
The third phase of the study was to analyse inter-tester reliability of the shoulder pain 
maps. Inter-rater or Inter-observer reliability is used to assess the degree to which different 
observers give consistent estimates of the same phenomenon (Trochim, 2006). Intertester 
reliability test was used in several studies and one of them was conducted with two 
hundred and fifty-five patients related to shoulder pain by Carter et al (2012). The current 
study’s inclusion criteria of patients were similar to that one. They included the patients 
with shoulder pain arising within the gleno-humeral or associated joints. They excluded 
the patients with previous shoulder surgery, complex problems and concurrent cervical 
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pain and/or radiculopathy. They used percentage agreement and Cohen's kappa coefficient 
as in our study. 
 
Participants:  
 
 
Three senior clinicians participated to the third phase of the study as tester / rater. One of 
the clinicians was a senior physiotherapist who had over 20 years of experience in sport 
medicine with a PhD degree, the other clinician was an experienced post-FRCS (Ortho) 
orthopaedic doctor and working in an upper limp unit, and third one was a consultant 
radiologist with musculoskeletal interest.   
 
Procedure:  
 
 
A brief explanation was given to each participant about the study and the previously 
established algorithm and colour-coded pain maps for shoulder pain diagnoses from the 
second phase. 
  
They were asked to code two estimations of diagnoses on a separate form for each patient 
of 194 from the second study using the algorithm and guidelines. The testers’ first 
estimations were coded according to whichever group of shoulder diseases the estimations 
were belong to and accordingly given a number of 1 or 2 (as below- next page).  
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       Patient  No: 
 
      1.Estimation 
 
             ACJ pathology                            Instability                                         Calcific Tendinitis                        
 
 
             Rotator Cuff tear                        Frozen Shoulder                                Impingement                                    GHJ Arthritis 
         
 
      2.Estimation 
 
            ACJ pathology                             Instability                                          Calcific Tendinitis                        
 
 
             Rotator Cuff tear                         Frozen Shoulder                                Impingement                                   GHJ Arthritis 
         
 
 
Data analysis:  
 
The data from each of three participant was collected and converted to an excel sheet. The 
diagnoses codes were correlated with actual groups of diagnoses to find out accuracy of 
testers’ estimation.  Moreover, the group codes were used to calculate the agreement in 
between the testers (Group 1 and group 2). Later, the best of both estimations of testers 
were used to calculate the accuracy on specific disease and again to calculate the 
agreement between the testers for specific diseases. This was discussed with the study 
supervisor and the level of agreement was tested with Kappa statistical test. These were 
analysed with Kappa values to observe a score of how much consensus or homogeneity 
there was for the algorithm of the shoulder pain maps. Kappa is typically is used to look at 
how accurately a test can be repeated.   
 
The excel sheet from the participants were transferred to statistics package (StatsDirect). 
Kappa co-efficient and inter-reliability tests were used to analyse this. Kappa (κ) of 0.5 or 
more is considered as good agreement and it is accepted of clinical significance. A value 
of 0.7 shows very good agreement. A κ of 1 means that there is perfect agreement (Harris 
& Taylor, 2008) (please refer to statistical terminology). The analysis was done using a 
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statistics package (StatsDirect). Opinion was sought from the local statistician for 
statistical analysis.  
 
Ethical Implications:  
 
This step did not include any additional treatment or investigations. The testers gave their 
verbal informed consent to contribute / join to the study. The participants had no financial 
interest in any product or service related to the study. 
 
 
In summary- Phase three  
Population: Adult patients (16 years and over), presented as a new patient with 
shoulder pain. 
Intervention: There was no intervention  
Comparison: To test the agreement between the testers using inter-tester reliability test  
Outcome measures: Their estimations were tested with Kappa values for their 
agreements to observe a score of how much consensus or homogeneity there was for the 
algorithm of the shoulder pain maps.  
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The aim of the study was to fill the gap in assessing patients as a whole for common 
shoulder disorders, to develop a pathway from a subjective experience of patients to 
diagnosis of the pathology, This prospective blinded study with the methods of the three-
phase gave a chance to study and analyse shoulder pain mapping extensively and 
vigorously.   
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Key Statistical Terminology 
 
Analysis of variance (ANOVA): this is a group of statistical techniques used to compare 
the means of two or more sample to see whether they come from the same population 
(Harris & Taylor, 2008). 
 
Blinding: A clinical trial design strategy in which one or more parties involved with the 
trial, such as the investigator or participant, who do not know which participants have 
been assigned to which interventions. Types of masking include none open label, single 
blind masking, double and blind masking (Clinical Trials, 2012). The opposite of a 
blinded study is described as an open label study (National Cancer Institute, 2012). 
 
Confidence intervals (CI): typically used when instead of simply planning the mean 
value of a sample, if it is a range that is likely to contain the true population value (Harris 
& Taylor, 2008). 
 
Kappa:  a comparison of how well tests agree. Kappa value can vary from zero to 1 and 1 
means that there is perfect agreement.  0.5 or more is considered a good agreement, a 
value of 0.7 shows very good agreement (Harris & Taylor, 2008). 
 
Positive predictive value:  the proportion of patients with positive test results who are 
correctly diagnosed (Altman and Bland, 1994a). 
Negative predictive value:  the proportion of patients with negative test results who are 
correctly diagnosed (Altman and Bland, 1994a). 
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Sensitivity: the proportion of true positives that are correctly identified by the test 
(Altman and Bland, 1994b). 
 
Specificity: the proportion of true negatives that are correctly identified by the test 
(Altman and Bland, 1994b). 
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Results 
The study was conducted in three phases; each phase had a different aim and was 
evaluated separately. The first phase aimed to ascertain different pain patterns for common 
shoulder disorders. It was a prospective study and Statistical Package for the Social 
Science (SPSS) 16 APA format was used to analyse demographic data and also to 
differentiate the pain distribution / radiation (the number of the affected cells/area) in the 
shoulder as well as the severity of the pain for each disease. However, the pain patterns 
were established manually from the excel sheets. 
 
The second phase of the study aimed to test accuracy of the established colour-coded 
shoulder pain patterns and once the final diagnoses were obtained, they were correlated 
with the estimated diagnoses. VassarStats (Lowry, 2013) was used for sensitivity and 
specificity and StatsDirect (2013) package was used for analysis of the other data such as 
age, agreement between estimation and diagnoses, agreement between map group and 
disease group. At the end of the second study, an algorithm on how-to-read shoulder pain 
maps was created.  
 
The third phase of the study aimed to analyse inter-tester reliability of the shoulder pain 
maps for three clinicians’ agreement level and the data was analysed with StatsDirect.  
The clinicians used the algorithm and the established colour-coded shoulder pain maps to 
test inter-tester reliability. 
 
     All the reports of statistical analysis were added to the appendices.  
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Phase One 
 
The first phase of the study included six shoulder disorders according to the adequacy of 
the number of patients for each disease once the results were analysed. The included 
disorders were acromioclavicular joint pathology, instability: Bankart’s, SLAP etc, calcific 
tendonitis, rotator cuff pathology, impingement syndrome, gleno-humeral joint arthritis.  
 
There was a distinct age difference between some of the disorders. For example, the 
patients with instability were generally younger than the other groups. The mean age of 
the instability group was 34.4 years (see table ii). This was followed by calcific tendonitis 
with 46.5 years. The oldest age group was gleno-humeral arthritis with an average of 69.8 
(table ii).  
 
Mean age- Phase one: 
 
Disorder 1-
ACJ 
2-
Instability 
3-Calc ten. 4-rot c. 6-imp 7-
GHJ 
Mean Age  
1.phase 
58.64 34.38 46.5 66.04 57.64 69.83 
 
Table ii: Mean ages for each disorder (Phase 1) 
(1-ACJ: Acromioclavicular joint pathology, 2-Instability: Bankart’s, SLAP etc, 3-Calc 
ten.: Calcific tendonitis, 4-rot c.: Rotator cuff pathology, 6- imp: Impingement syndrome, 
7- GHJ: Gleno-humeral joint  arthritis ) 
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Note: number 5 was not included to the table to avoid any confusion as number 5 is frozen 
shoulder when the results are combined with the second phase of the study.  
 
Shoulder pain patterns and distributions for each shoulder disorder were obtained by 
observing and checking the excel data sheet manually in the first phase of the study and 
the summary is shown on the table below (see table iii). (Please note that number 5 is 
frozen shoulder and it is empty on the table as it was not included in the first phase.) The 
table content was converted to colour-coded shoulder maps at the end of the first phase 
(see figures II-i, ii, iii, iv-a, vi and vii in appendices). 
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The shoulder pain distribution table according to the pain types, region and 
disorders from the first phase of the study: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table iii: Types and radiation of shoulder pain- phase one (Bayam et al., 2011) 
       (N: number of the patients with type of pain description, 1-Acromioclavicular joint 
pathology, 2-Instability: Bankart’s, SLAP etc, 3- Calcific tendonitis, 4-Rotator cuff 
pathology, 5-Frozen shoulder, 6- Impingement syndrome, 7-Gleno-humeral joint 
arthritis,S: sharp,shooting or stabbing pain, D: dull or aching pain, B: burning pain, P: 
pins&needles / numbness)  
           * 7 patients with impingement syndrome had described pins & needles sensation in 
their hands, mainly on the dorsum. These patients were assessed to exclude particularly 
other distal upper limb problems for example carpal tunnel syndrome and other nerve 
compression disorders. 
          **Frozen shoulder (5) was not included in the first study as one of the diagnosis.   
    
 
 
 
 
 
 
 
 
Types of 
pain and 
regions:  
Overall: 
both 
anterior&post
erior 
 
Predomina
nt Pain 
types 
around 
shoulder 
N:  
 
Predomina
nt Pain 
types 
around  
arm 
N: 
Predomi
nant 
Pain 
types 
below 
elbow  
N:  
S D B P S D B P S D B P 
Diagnosis 
 
1 12 1 1   5    2   
2 8 9 1  4 4  1     
3 5 1   4  1      
4 15 7   3 11  1 3 8  1 
5 **             
6 18 6 4  8 16 2 1 3 9  7* 
7 3 2 1  3 2 1  3 2   
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    Character and Radiation of Pain for Common Shoulder Disorders 
 
 
Pain from ACJ pathology was predominantly localised to the anterior aspect of the 
shoulder and was sharp and stabbing in nature. Pain did not radiate down the forearm. The 
area of pain distribution was smallest among all the disorders (figure II-i, table iii). 
 
The patients with shoulder instability including SLAP (Superior Labrum from Anterior to 
Posterior) and Bankart`s lesions had predominately localised pain around the shoulder. It 
was a mixture of sharp and dull pain in character without radiation to the forearm or even 
not to the elbow (figure II-ii, table iii). They were younger than the other disease groups 
(table ii).  
 
The patients with calcific tendonitis described predominantly a sharp / shooting pain in the 
region of the shoulder with no radiation to the elbow or hand (figure II-iii, table iii). 
 
Patients with rotator cuff tears demonstrated sharp pain around the shoulder and radiating 
dull / aching pain down to the elbow and the forearm (figure II-iv-a, table iii). 
 
 
The patients with impingement syndrome showed sharp pain around the shoulder and 
radiating dull / aching pain down to the forearm. It was similar to rotator cuff pattern, 
however, there was pins & needles / numbness around the hand (figure II-vi, table iii). 
 
In GHJ arthritis, a mixed pattern of pain was described that was sharp, shooting, burning 
and dull aching in nature and affected nearly the entire arm, from shoulder to hand (figure 
II-vii, table iii).  
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Burning sensation was rarely described. When described, this was mainly by patients who 
had impingement and GHJ arthritis (table iii). 
 
The Distribution Area of Pain and the Severity (First Phase Study): 
 
Using SPSS 16.0, statistical package, P-P plot for distribution showed that both the 
severity of the pain and the number of the areas were normally distributed. On analysis of 
the VAS scores, GHJ arthritis patients had the most severe pain with a mean score of 7.83 
/ 10, closely followed by patients with impingement with a mean score of 7.80. The least 
severe pain was described by the patients with ACJ pathology, the mean was 6.43 / 10. 
Similarly, the value for instability patients was 6.72 / 10. The remaining VAS pain 
severity scores were 7.05 and 7.50 for rotator cuff tears and calcific tendinitis respectively 
(table iv). Statistically, there was not a significant difference in the range of pain between 
the diagnoses (F (5, 87)= 1.138, p=0.347). 
 
The pain map consisted of a total of 28 marked sections or cells, 14 on each side of the 
arm (figure I). Analysis demonstrated how well the pain localised in a specific area for 
each particular shoulder condition (table iv). This ranged between 3.86 for ACJ pathology 
to 12.5 for gleno-humeral arthritis, indicating the diffuse nature of pain from GHJ arthritis 
and the pinpoint nature of pain from ACJ pathology. 
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The table for distribution area of pain and the severity: 
 
 
Diagnosis 1 2 3 4 6 7 
Number 
of cells 
(mean) 
3.86 6.88 5.5 5.60 7.21 12.5 
Severity 
of pain 
(VAS) 
6.43 6.72 7.5 7.05 7.80 7.83 
 
 
Table iv: 1- The mean of total number of cells marked by the patients (regardless the 
type of pain) (in total, there were 28 cells anteriorly&posteriorly on the map) and 2- 
the severity of the pain  (VAS) for each disease. 
 
(1-Acromioclavicular joint pathology, 2-Instability: Bankart’s, SLAP etc, 3- Calcific 
tendonitis, 4-Rotator cuff pathology, 6- Impingement syndrome, 7-Gleno-humeral joint 
arthritis) 
Note: There is no number 5 on the table. In the combined results, number 5 is frozen 
shoulder. To avoid any confusion, number 5 was kept empty on the table  
 
Whilst Pearson’s correlation tests demonstrated statistically weak correlation between the 
number of the areas and severity of the pain (r=0.194, p= 0.64), however, one-way 
ANOVA showed a meaningful difference in the number of areas marked by the patients 
between the groups (F (5, 87) = 3.550, p=0.006). Post hoc multiple comparisons showed 
meaningful differences were especially between GHJ and rotator cuff tears (p= 0.014) and 
also, between GHJ arthritis and ACJ pathology (p= 0.002). 
 
At the end of Phase one, all the colour-coded maps were established for the above six 
shoulder disorders (figure II  i, ii, iii, iv-a, vi and vii) and these were used to be tested in 
the second phase of the study.  
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Phase Two 
 
In this phase, the final diagnoses were correlated with the estimated diagnoses. One aim of 
the second phase was to recruit many more patients to the study in order to test the colour-
coded shoulder pain maps and improve these if required. Despite the initial inclusion and 
exclusion criteria, many more patients (128) were included initially but, excluded from the 
study at later stage. 34 of them were excluded due to inappropriate marking such as using 
different marks, illegible marks, or not marking the forms at all, although they all have 
been explained about how to fill the forms. 30 of them were excluded due to insufficient 
clinical information or documentation about their diagnoses (probably related to drop out 
or loss to follow-up).  14 of them were excluded due to previous shoulder operation on the 
same shoulder. 25 of them were excluded due to multiple shoulder problem/diagnoses. 
And 25 of them were excluded due to irrelevant/different diagnoses, which were not 
within the framework of this study such as metastatic disease or neurological disorders as 
well as neck problems which were missed during the initial exclusion. 194 patients were 
included in the second study. 
 
Mean Age- Phase Two 
 
The mean age of the instability group was 28.8 years in the second study (see table v). 
This was followed by calcific tendonitis with 43 years. The oldest age group was gleno-
humeral arthritis with an average of 65.5 (table v). These results were similar to phase one 
results (see above, table ii).  
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Mean  age- Phase two: 
 
Disorder 1-
ACJ 
2-
Instability 
3-Calc ten. 4-rot c. 5- frozen 6-imp 7-
GHJ 
Mean Age  
2. phase 
48.4 28.8 43.0 53.4 51.8 49.5 65.5 
 
Table v: Mean ages for each disorder (Phase two) 
(1-ACJ: Acromioclavicular joint pathology, 2-Instability: Bankart’s, SLAP etc, 3-Calc 
ten.: Calcific tendonitis, 4-rot c.: Rotator cuff pathology, 5-frozen: Frozen shoulder, 6- 
imp: Impingement syndrome, 7- GHJ: Gleno-humeral joint  arthritis ) 
 
All the patients (194) had clinical examination, antero-posterior, axillary and 
supraspinatus outlet views of the affected shoulder and shoulder ultrasound by a senior 
upper limb surgeon as part of their clinical assessments. In addition to the initial 
investigations, which were x-rays and ultrasound scans, on the day of first assessment, 55 
patients had MR arthrogram, 39 patients had MR scan and 10 patients had CT arthrogram 
later. In total, 117 patients had further scans / investigations (table vi).  
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The table for further scans- phase two:  
 
Further Scans (117 out of 194 in total) 
MR scan  MR 
Arthrogram 
CT 
Arthrogram 
Shoulder 
Arthrography 
39 55 10 13 
 
Table vi: Further imaging in addition to the investigations on the first day  
 
130 patients out of 194 had surgery, 14 patients had arthrographic hydrodilatation, 9 
patients had injection and physiotherapy, 14 patients had physiotherapy, 21 injection and 3 
ultrasound guided removal of calcium deposits (barbotage). In total, 191 out of 194 
patients in the second study had further treatment for their shoulder disorders (table vii). 
 
The table of further managements for patients’ shoulder disorders 
 
Operation Hydrodilation PhysiotherpyAnd 
injection 
Physiotherapy injection u/s  
guidance 
removal 
of ca 
deposits 
No 
further 
treatment 
130 14 9 14 21 3 3 
 
Table vii: Treatments of patients with shoulder disorders- phase two 
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In the second phase, the diagnoses were established after completion of all the 
investigations, assessments, treatments, operations and follow-ups. 
 
Testing Colour-coded Shoulder Pain Maps 
 
The accuracy of the first diagnoses for individual disorders was 45.4% (88 correct 
diagnoses out of 194) and when including the second estimations, the accuracy was 62.4 
% (121 out of 194). 22 out of 194 patients were diagnosed with frozen shoulder, which 
were included in those percentages.  
 
Prediction of researcher on diagnoses of shoulder disorders using colour-coded 
shoulder pain maps: 
 
 
Table viii: Prediction of diagnoses by the researcher 
 
(**Note: 22 of the patients were diagnosed with frozen shoulder, which did not have an 
established pattern/map in the first phase of the study)   
Diagnosis 1
st
 estimated 
diagnosis 
2
nd 
estimated
 
diagnosis 
TOTAL 
Correct 
diagnosis 
Not 
diagnosed 
Total 
patients 
1-ACJ path. 13 12 25 
(86.2%) 
4 29 
2-Instability 47 4 51 
(89.5%) 
6 57 
3-Calcific 
tend. 
2 3 5 
(71.4%) 
2 7 
4-Rotator 
cuff 
5 3 8 
(38.1%) 
21 29 
5-Frozen 
shoulder** 
0** 0** 0** 22** 22 
6-
Impingement 
20 10 30 
(65.2%) 
16 46 
7-GHJ 
arthritis 
1 1 2 (50%) 2 4 
 
Total 
88 33 121 
(62.4%) 
73 194 
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There was a high prediction rate for instability and ACJ pathology and it was low for 
rotator cuff pathology (table viii).  
 
The table for sensitivity and specificity of estimations using shoulder pain maps: 
 
 
 
 
 
 
 
 
 
 
Table ix: Sensitivity and specificity of estimations for each shoulder disorders 
 
According to the above table (ix), in the study, the estimations for the diagnoses of the 
maps were most sensitive for instability. The patients with instability had mostly shown 
and marked the same pattern for their pain. This was followed by impingement and ACJ 
pathology. It was least sensitive for rotator cuff and GHJ arthritis. However, there were a 
very small number of the patients with GHJ arthritis.  
 
 
 
 
Diagnosis Sensitivity  Specificity 
1-ACJ path. 0.62 0.97 
2-Instability 0.78 0.85 
3-Calcific tend. 0.5 0.99 
4-Rotator cuff 0.33 0.95 
6-Impingement 0.67 0.93 
7-GHJ arthritis 0.33 0.99 
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Table x, xi and xii were used to evaluate the pain patterns of common shoulder disorders 
and these were combined with the results from the first phase to describe and improve the 
colour-coded patterns. Besides, these tables helped establishing pain mapping algorithm.  
 
The Pain distribution tables from the second phase of the study: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table x: Overall shoulder pain distribution (without pain type description) – second 
phase of the study 
                            
(N: number of the patients, 1-Acromioclavicular joint pathology, 2-Instability: Bankart’s, 
SLAP etc, 3- Calcific tendonitis, 4-Rotator cuff pathology, 5-Frozen shoulder, 6- 
Impingement syndrome, 7-Gleno-humeral joint arthritis, S: sharp, shooting or stabbing 
pain, D: dull or aching pain, B: burning pain, P: pins & needles / numbness) 
Types of 
pain and 
regions:  
Overall 
results 
 
 Pain 
around 
shoulder 
N:  
 
 Pain 
aroun
d 
upper  
arm 
N: 
Pain around 
elbow N: 
 Pain below 
elbow N:  
    
Diagnos
is N 
 
129 28 
95.6% 
8 
27.6% 
2 
6.9% 
0 
257 100% 26 
45.6% 
3 
5.3% 
1 
1.8% 
37 100% 4 
57.1% 
1 
14.3% 
0 
4 29 100% 21 
 
72.4% 
8 
27.6% 
4 
13.8% 
522 21 
95.5% 
20 
90.9% 
13 
59% 
8 
36.4% 
646 100% 40  
87% 
 
29 
63% 
20 
43.5% 
74 100% 100% 3 
75% 
3 
75% 
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   The summary table of pain types and distribution anteriorly for each shoulder  
   disorder- phase two:  
 
 
*= non-dominant pain in that region 
 
 
Table xi: Types of shoulder pain and regions anteriorly, second phase 
 
 
(N: number of the patients, 1-Acromioclavicular joint pathology, 2-Instability: Bankart’s, 
SLAP etc, 3- Calcific tendonitis, 4-Rotator cuff pathology, 5-Frozen shoulder, 6- 
Impingement syndrome, 7-Gleno-humeral joint arthritis, S: sharp, shooting or stabbing 
pain, D: dull or aching pain, B: burning pain, P: pins & needles / numbness ) 
 
 
Types of 
pain and 
regions:  
Overall: 
anterior  
 
Predominant Pain 
types around 
shoulder 
N:  
 
Predominant 
Pain types 
around  arm 
N: 
Predominant Pain 
types below elbow  
N:  
S D B P S D B P S D B P 
Diagnosis
 N 
 
129 20 
69% 
5 
17.4
% 
6* 
2*  2 
6.9% 
6 
 
20.7
% 
   2 
6.9% 
 1 
3.4% 
257 43 
 
 
75.4% 
12 
21% 
 
34* 
6*  6 
10.5
% 
13 
22.8
% 
 
3* 
2 
 
1* 
    5  
8.8% 
37 5 
71.4% 
1 
14.3
% 
4* 
1*  1 
14.3
% 
2 
 
28.6 
% 
   1 
14.3
% 
 1 
14.3% 
4 29 20 
 
69% 
8  
27.6
% 
 
7* 
1 
3.45
% 
 
10* 
 10 
34.5
% 
7 
 
24.1
% 
 
3* 
2 
6.9
% 
 1 
 
3.4
% 
5 
17.2
% 
 5 
 
17.2% 
522 17 
77.3% 
2 
9% 
5* 
4*  6 
27.3
% 
11 
50
% 
1 
4.5
% 
 3 
13.6
% 
7 
31.8
% 
 3 
13.6% 
646 32 
70% 
8 
17.4
% 
1 
2.17
% 
 10 
21.7
% 
26 
56.5
% 
1 1 20 
43.5
% 
 13 
28.3% 
 
74 4 
100% 
 
2* 1* 1
* 
3 
75% 
1* 1*  2 
50
% 
1  
25% 
1* 
 1 
25% 
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   The summary table of pain types and distribution posteriorly for each shoulder  
   disorder- phase two:  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                       The table continues to the next page                   
Types of pain 
and regions:  
Overall: 
posterior 
 
Predominant 
Pain types 
around shoulder 
N:  
 
Predominant 
Pain types 
around  arm 
N: 
Predominant 
Pain types 
below elbow  
N:  
S D B P S D B P S D B P 
Diagnosis N 
 
129 12 
41.4
% 
5 
17.
25
% 
  1 
3 
2 
6.9
% 
      
257 25 
43.9
% 
13
22.
8
% 
23
* 
1 
1.
8
% 
 
6* 
 6 
1
0
.
5
 
% 
6 
10.
5 % 
2* 
   3 
5.
3
% 
 4 
7% 
37 5 
71.4
% 
1*   2 
6 
1 
14.
3% 
      
4 29 9 
31% 
11 
38
% 
 
1 
3.
4
% 
5* 
 3 
1
0
% 
4 
13.
8% 
1
* 
  3 
10
% 
 1 
3.4
% 
522 14 
63.6
% 
2 
9
% 
1 
4.
5
% 
 2 
9
% 
7 
31.
8% 
  1 
4.
5
% 
8 
36
.4
% 
1 
4
.
5
% 
2 
9% 
646 20 
43.5
% 
12 
26
% 
16
* 
6*  8 
1
7
. 
17 
40
% 
3* 
1 
2.2
% 
1* 
  16 
34
.8
% 
1* 
1 
2
.
2 
 
8 
17.
4% 
74 3 
75% 
 
1* 
  2 
5
0
% 
1*   1 
25
% 
1 
25
% 
 1 
25
% 
                                                                                                          Levent Bayam @00279526    
80 
 
 
 
*= non-dominant pain in that region 
   
Table xii: Types of shoulder pain and regions posteriorly, second phase 
  
(N: number of the patients, 1-Acromioclavicular joint pathology, 2-Instability: Bankart’s, 
SLAP etc, 3- Calcific tendonitis, 4-Rotator cuff pathology, 5-Frozen shoulder, 6- 
Impingement syndrome, 7-Gleno-humeral joint arthritis, S: sharp, shooting or stabbing 
pain, D: dull or aching pain, B: burning pain, P: pins & needles / numbness ) 
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Pins & needles or numbness in the hands and wrists were mostly described by patients 
with impingement syndrome in both studies [25% (7/28)   and 30 % (14/46) in the first 
and second phases study, respectively]. Despite high percentage of pins & needles in GHJ 
arthritis, the total number of patients with the disorders was very low (table xiii). 
 
 
Numbness in the hand and wrist in the second phase of the study: 
Diagnosis (N) Number of patient 
with numbness / pins 
& needles in the hand 
(N) 
Total Percentage of 
numbness or pins & 
needles  in the hand 
and wrist  
1- ACJ pathology (29) 2 in total (out of 29)     
2 front 
0 back 
6.9% 
2- Instability (57) 7 in total (out of 57) 
5 front 
4 back 
12.3% 
3- Calcific 
Tendinitis(7) 
1 in total (out of 7) 
1 front 
0 back 
14.3% 
4- Rotator cuff (29) 4 in total (out of 29) 
4 front 
 1 back 
13.8% 
5- Frozen shoulder(22) 3 in total (out of 22) 
3 front 
2 back 
13.6% 
6- Impingement (46) 14  (out of 46) 
11 front 
8 back 
30.4% 
7- GHJ arthritis (4) 2 in total (out of 4) 
1 front 
1 back 
50% (small number of 
patients) 
 
Table xiii: Numbness / pins & needles in the hand and wrist 
(N: number of the patients) 
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In the light of the results in testing the colour-coded shoulder maps, the second step phase 
had revealed mainly a problem with rotator cuff pathology in the initial pain patterns. 
Therefore, it was analysed again using the combination of maps from both the first and 
second phases, which led to some modification in its description and pattern which were 
slightly changed accordingly. Following the analysis of the second study phase, another 
disorder, frozen shoulder was also added as a new pattern. The colour-coded mapping of 
frozen shoulder was produced in addition to the previous six shoulder disorders which 
were included in the first phase. 
 
 
Additional Changes to Phase One Results in Distribution and Character of 
Pain in Shoulder Disorders  
 
As the testing of phase one results revealed some problems with rotator cuff pattern, the 
description about rotator cuff changed using the combined results of shoulder pain maps 
from both phase one and two studies. Also, the paragraph on impingement syndrome 
changed as below:  
 
Patients with rotator cuff tears demonstrated sharp pain around the shoulder and radiating 
dull / aching pain towards the elbow. Mostly, the pain was limited to around the elbow and 
was not radiating down to the forearm or hand (figure II-iv-b, table x, xi, xii). 
 
 
The patients with impingement syndrome showed sharp pain around the shoulder and 
radiating dull / aching pain down to the forearm. It was similar to rotator cuff pattern, 
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however, there was further radiation of the pain below elbow as well as pins & needles / 
numbness around the hand (figure II-vi, table x, xi, xii). 
 
Frozen shoulder showed a pattern of mostly sharp widespread pain around the  shoulder 
mixed with burning pain and radiation to elbow which was distributed posteriorly around 
the arm down to elbow level but generally no radiation below the elbow level (figure II-v, 
table  x, xi, xii). 
 
Burning sensation was described by the patients who were diagnosed with frozen shoulder 
in addition to the patients with impingement and GHJ arthritis even though this pain type 
was rarely marked on the map by the patients (table iii, x, xi, xii). 
 
At the end of the second phase, all tables from phase one and two were combined and 
common shoulder disorders were classified according to the pain patterns, character and 
distribution as explained in the next section. The age was added to the algorithm for group 
one (the pain localised around the shoulder, see algorithm) but for group two, the age did 
not contribute to the differential. The severity of the pain was not included because this 
did not show a significant statistical difference between the groups in the first phase of 
study. 
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Classification of Common Shoulder Disorders According to Pain 
Distribution / Radiation   
 
Since both phase one and some part of phase two looked into the same details on patients’ 
experience to diagnoses of shoulder pathologies and the results of  two phases were 
combined here to classify the pain patterns for common shoulder disorders. Seven 
common shoulder disorders were identified on the patients who presented to the shoulder 
clinic and filled the custom-made shoulder pain maps. According to the pain distributions 
of the seven shoulder disorders, they were divided into two groups based on the 
distribution of the pain area whether localised to shoulder or not. They were called as 
group 1 and group 2; group 1 represented the disorders with shoulder pain localised only 
around shoulder (ACJ pathology, Calcific tendinitis, and instability) and group 2 
represented the disorders that the pain radiates beyond shoulder (rotator cuff pathology, 
frozen shoulder, impingement, and GHJ arthritis). Later, the second group was also 
divided into two subgroups based on further radiation of the pain. 
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Classification of Common Shoulder Disorders 
 
Group 1: Pain localised around shoulder  
                Disease  1: Acromioclavicular (ACJ) pathology 
                              2: Instability (Bankart’s, SLAP etc) 
                              3: Calcific tendonitis 
Group 2:  Pain radiating beyond shoulder 
                 A- To around elbow 
                             4: Rotator cuff pathology 
                             5: Frozen shoulder 
                B- Beyond elbow-down to the hand 
                             6: Impingement syndrome 
                             7: Gleno-humeral joint (GHJ) arthritis 
 
When the diseases were divided into two groups (group 1 and 2) according to the pain 
distribution (group 1: localized to the shoulder, group 2: radiation beyond shoulder) as per 
the classification above, the agreement between map group and disease group was 
analysed. It showed a substantial agreement between the two groups (81.96%) (Observed 
agreement = 81.96%, Expected agreement = 50.28%, Kappa (κ) = 0.64,   95% confidence 
interval = 0.50 to 0.78, P < 0.0001). 
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The sensitivity of maps for group match was 0.76 for group 1 and 0.87 for group 2. The 
specificities were 0.87 and 0.76 for group 1 and group 2, respectively (table xiv). 
 
 The table for estimation of disease groups matching shoulder pain maps: 
Estimation of Disease Group  Sensitivity  Specificity 
Group 1 diseases (ACJ path, 
Instability, Calc. tend.) 
0.76 0.87 
Group 2 diseases (Rot.Cuff. 
frozen, impingement, GHJ arth.)  
0.87 0.76 
 
Table xiv: Estimation of Disease Group, sensitivity and specificity 
 
(ACJ path: Acromioclavicular joint pathology, 2-Instability: Bankart’s, SLAP etc, 3-Calc 
tend.: Calcific tendonitis, 4-rot cuff.: Rotator cuff pathology, 5-frozen: Frozen shoulder, 6- 
impingement: Impingement syndrome, 7- GHJ arth: Gleno-humeral joint  arthritis)              
 
Following the analysis of the second step of the study, an algorithm is formed as below. 
This aimed to provide guidance about how to read the shoulder pain maps as well as to 
assist facilitating the third phase of the study for inter-tester reliability. 
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Shoulder Pain Mapping Algorithm 
 
 
The extension of the marked area of pain from less to more (the numbers shows the 
disorder codes): 
1 <  2  <  3  <  4  <  5  <  6  <  7 
 
Figure III: Shoulder Pain Mapping Algorithm 
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Phase three: 
 
In the third phase, all three testers / raters gave two estimations for each map of 194 
patients using the algorithm and the established colour-coded pain maps for shoulder 
disorders and their best estimations were used for statistical analysis; estimation of 
diagnoses, agreement between testers / raters about these estimations, sensitivity and 
specificity for individual shoulder disorders. However, only their first estimations were 
used to analyse the disease group; sensitivity and specificity for disease groups and 
agreement between testers / raters. 
 
Estimating the Disease Group:  
 
There were high estimation ratios for the disease groups (group 1 and 2) of shoulder in the 
raters’ first estimation. Rater A had an estimation of 75.26%, whilst Rater B and Rater C 
had 81.44% and 80.93 respectively (table xv).  
 
The table of estimations by testers: 
Raters 
/ 
testers 
Expected 
agreement 
Observed 
agreement 
P value 
A 49.87% 75.26% P < 0.0001 
 
B 50% 81.44% P < 0.0001 
 
C 50.23% 80.93% P < 0.0001 
 
 
 
Table xv: Estimation of Disease Groups by Three Testers 
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Furthermore, the results showed high sensitivity and specificity for the disease group, 
which was obtained from the estimations of the testers.   
 
The raters’ estimations about the disease groups: 
Disease 
Group  
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity 
 Rater A Rater A Rater B Rater B Rater C Rater C 
Group-1 0.80 0.71 0.83 0.80 0.76 0.85 
Group-2 0.71 0.80 0.80 0.83 0.85 0.76 
 
 
Table xvi: Sensitivity and specificity for the disease groups 
 
 
 
The table xvii shows a substantial agreement between the raters on the estimation (first 
estimation) of disease groups.  
 
The table of agreement between raters: 
 
 
Table xvii: Agreement of the raters on the disease groups  
 
 
 Expected 
agreement 
Observed 
agreement 
Kappa (κ) P 
Between 3 
raters 
  0.70 P < 0.0001 
 
Between 
rater A and 
B 
50% 82.5% 0.65 P < 0.0001 
 
Between 
rater A and 
C 
49.65% 81.96% 0.64 P < 0.0001 
 
Between 
rater B and 
C 
50% 90.21% 0.80 P < 0.0001 
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Estimating the Diseases Individually: 
 
The matching of best estimations of three raters with the final diagnoses of individual 
shoulder disorders were from 58 to 64 %.  
 
The table of estimations of raters on the individual shoulder disorders:  
 
Raters / 
testers 
Expected 
agreement 
Observed 
agreement 
P value 
A 19.41% 60.82% P < 0.0001 
 
B 19.39% 63.92% P < 0.0001 
 
C 17.35% 58.25% P < 0.0001 
 
 
 
Table xviii: Best estimation of individual shoulder disease by raters 
  
Sensitivity shows the proportion of the patients with the disease, whose tests are positive 
and specificity shows the probability that the patients do not have the disease when they 
are disease free (Faragher, 2005). The table shows constantly higher sensitivity of map 
estimation for instability and also better results for rotator cuff disorders after the 
improvement following the second step of the study (table xix).   
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The table of sensitivity and specificity of testers for individual shoulder disorders: 
Diagnosis Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity 
 Rater A Rater A Rater B Rater B Rater C Rater C 
1-ACJ 
path. 
0.55 0.90 0.51 0.96 0.55 0.93 
2-
Instability 
0.74 0.89 0.81 0.97 0.65 0.96 
3-Calcific 
tend. 
1 0.97 0.43 0.99 0.71 0.95 
4-Rotator 
cuff 
0.55 0.87 0.72 0.88 0.52 0.84 
5-Frozen 
Shoulder 
0.55 0.95 0.32 0.94 0.55 0.95 
6-Impinge-
ment 
0.5 0.93 0.54 0.92 0.52 0.95 
7-GHJ 
arthritis 
0.5 0.99 0.25 0.97 1 0.94 
 
Table xix: Sensitivity and Specificity Results of Testers for Individual Shoulder 
Disorders 
(ACJ path: Acromioclavicular joint pathology, 2-Instability: Bankart’s, SLAP etc, 3-
Calcific tend.: Calcific tendonitis, 4-rotator cuff.: Rotator cuff pathology, 5-frozen: Frozen 
shoulder, 6- impingement: Impingement syndrome, 7- GHJ arthritis: Gleno-humeral joint  
arthritis) 
 
There were also constantly similar sensitivity values for ACJ pathology and impingement 
syndrome.  
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The agreement of estimation between 3 testers who gave 2 estimations for each map was 
calculated and their best estimation was used for statistical analysis. It showed a 
substantial agreement between the raters (Kappa (κ) = 0.71) (table xx). 
 
The table of overall agreements between the raters:  
  
 
 
 
 
 
 
 
 
 
 
 
Table xx: General agreement over all (7) categories with 3 raters per disease  
 
 
 
 
 
 
 
Disease Kappa(κ) 
1-ACJ path. 0.77 
2-Instability 0.73 
3-Calcific tend. 0.62 
4-Rotator cuff 0.66 
5-Frozen 
Shoulder 
0.67 
6-Impingement 0.77 
7-GHJ arthritis 0.53 
Overall 0.71 
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The agreement of estimations for individual diseases between raters (A and B, B and C, A 
and C) was very good (table xxi).  
 
 
The table of agreement between raters on individual shoulder disorders: 
 
 Expected 
agreement 
Observed 
agreement 
Kappa P 
Between 
rater A and B 
19.13% 88.14% 0.85 P < 0.0001 
 
Between 
rater A and C 
17.59% 82.47% 0.79 P < 0.0001 
 
Between 
rater B and C 
19.17% 93.78% 0.92 P < 0.0001 
 
 
 
Table xxi: Raters agreement on the estimations of the individual shoulder 
disorders  
 
 
In summary, the results section showed establishing colour-coded shoulder pain maps in 
the first phase, testing these, improving them and establishing an algorithm about how-to-
read shoulder pain maps in the second phase and assessing the inter-tester reliability by 
raters for both the disease groups and individual shoulder disorders in the third phase. 
These results were discussed in the next section in the light of existing literature.    
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Discussion: 
 
This chapter discussed and analysed the results of the three phases in light of the existing 
published studies. It included a summary of the study and results, discussion on pain 
distribution, sensitivity - specificity - reliability, pain maps, limitation and conclusion. 
 
Pain mapping for specific disorders was described in the literature for face, back and hip 
pain, but not for shoulder pain. Literature search revealed a gap in this area. The aim of the 
study was to fill the gap in assessing patients as a whole for common shoulder disorders, 
to develop a pathway from a subjective experience of patients to diagnosis of the 
pathology, to ascertain specific patterns of pain in patients with common shoulder 
disorders, to describe comprehensive shoulder pain maps and to test these.  
 
The study was conducted in three phases to achieve the above aims. A prospective blinded 
study was used in the first phase to achieve establishing pain patterns for common 
shoulder disorders and six specific patterns of shoulder diseases were described. The 
colour-coded pain maps were acromioclavicular joint pathology, instability: Bankart’s, 
SLAP etc, calcific tendonitis, rotator cuff pathology, impingement syndrome, gleno-
humeral joint arthritis. The first phase included 94 patients. 
 
Although the pain severity was not statistically significant, there was a difference 
especially between ACJ pathology, instability and GHJ arthritis. Trend for severity of the 
pain showed lower VAS for ACJ and higher VAS for GHJ arthritis. Although it was not 
statistically significant, with greater number, the trend may be important however, equally it 
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may remain not important. On analysis of the pain distribution, it indicated the diffuse 
nature of pain from GHJ arthritis and the pinpoint nature of pain from ACJ pathology.  
The second phase aimed to test these maps with another prospective blinded study and 
with a larger group of patients. The accuracy of mappings was tested. The provisional / 
estimated diagnoses were marked immediately by the researcher, who was blind to the 
diagnoses, after each shoulder map marked by the patients. However, the coding of the 
diagnoses for those patients in the second study was delayed until all the operations and 
postoperative outpatient follow-ups were completed in order to obtain the final and 
definitive diagnoses.  The second study included 194 patients.  
 
The second phase showed high sensitivity especially for instability as well as good 
sensitivity for ACJ pathology and impingement syndrome. The results for rotator cuff 
pathology were poor initially; however, the description of its pattern had been improved 
accordingly.  Another shoulder disorder was added to previous six diagnoses, which was 
frozen shoulder. 
 
At the end of the second phase, the previously established shoulder pain patterns were 
improved. Two main groups of diseases were described according to the pain distribution / 
radiation and the shoulder disorders were classified accordingly. There was good 
agreement between the map group (1 and 2) and the disease group (1 and 2). An algorithm 
was developed to guide the testers/ raters of the third phase on how-to-read the shoulder 
pain maps.  
 
The third phase aimed to test inter-tester reliability with three testers and it achieved this 
with blinding of the testers to the diagnoses on a large group of patients (194 patients from 
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the second phase of the study). Three testers gave their estimations according to the 
algorithm and the established colour-coded shoulder pain maps. The results showed a 
substantial agreement between testers for both disease groups and the individual shoulder 
diseases, which indicates the reliability of the algorithm and established colour-coded 
maps. Likewise, sensitivity and specificity for both disease groups and individual shoulder 
disorders were tested and calculated.  
 
The above summary of the study was discussed further as below. 
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Pain Distribution: 
 
The current study showed specific pain patterns for common shoulder problems. Many 
different shoulder disorders cause similar symptoms and patterns of pain (Larson et al., 
1996). In the literature, there were some studies which attempted to specify the pain 
patterns as well as the current study. Gerber, Galantay and Hersche (1998) aimed to 
ascertain the distribution of ACJ and subacromial impingement pain by injecting 
hypertonic saline into the ACJ and subacromial spaces of normal subjects. ACJ irritation 
resulted in “burning” pain felt over the joint, deep in the supraspinatus fossa and in the 
upper trapezius. This is similar to our findings in the mapping of ACJ pain, where pain 
was mainly localised to the anterior and dorsal aspect of the shoulder but differed in the 
distribution of pain down the posterior aspect of the arm. The pain was mainly stabbing in 
nature but also had dull and burning components. 
 
The results from the current pain mapping study showed localised shoulder pain for 
certain shoulder conditions such as instability, calcific tendonitis and ACJ pathology. In 
instability, as well as sharp element of the pain, there was strong description of dull pain 
by the patients and majority of patients were younger than 40 years old in the current 
study. The pain distribution for calcific tendinitis in some literature was described as from 
the point of the shoulder to the deltoid insertion commonly and, less frequently, to the 
neck (Woodward, 2013), which is not much different than the current study’s findings. In 
the current study, this was generally described as sharp pain by the patients, and 
occasionally with mixed nature of sharp and dull pain only around the shoulder area with 
no radiation below the shoulder. The nature of this pattern with wider area involvement 
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and mixture character of the pain was different from the ACJ pathology despite localized 
nature of the pain. 
 
On the contrary, there were differences between the current study and previous literature 
in relation to radiation of the pain for other shoulder disorders. A far greater radiation of 
pain occurred in impingement syndrome and gleno-humeral arthritis in our study. 
Subacromial irritation in Gerber’s paper resulted in an “intense” pain mainly in the lateral 
border of the acromion and the lateral portion of the deltoid muscle (Gerber et al., 1998). 
Dutton describes the pain due to rotator cuff pathology and impingement is usually felt 
over the anterior or lateral part of the shoulder and he mentions that this pain is 
characterised by radiation down the upper arm, and is aggravated with overhead activities.  
However, the pain that radiates beyond the elbow is far less likely to be due to shoulder 
pathology, particularly if it is associated with any sensory disturbance in the limb such as 
distal radiation or pain, numbness or paresthesia (Dutton, 2008). Similarly, Woodward and 
Best (2000) concluded that the pain related to impingement usually occurs over the 
anterolateral aspect of the shoulder, often with some radiation to, but not usually beyond, 
the elbow.  
 
Besides, they mention that in frozen shoulder, the discomfort is localised near the deltoid 
insertion. Whereas, our two studies uniquely showed that at least two of the common 
shoulder diagnoses, impingement syndrome and gleno-humeral arthritis, show pain 
radiation beyond the elbow and some associated sensory disturbance. Furthermore, the 
current study showed that around 60% of the patients with frozen shoulder described their 
pain radiating down to elbow level. Frozen shoulder pattern was described in the second 
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phase of the study and there were some similarities to rotator cuff pathology pattern, yet, 
frozen shoulder pain was marked by the patients more widespread on the pain map than 
the pain distribution described for rotator cuff. 
 
Pins & needles / numbness, which 30 % of the patients described around the hand in 
impingement syndrome also shows the extension of radiation of the pain in those patients. 
It is an interesting finding that the patients with impingement syndrome constantly 
described this symptom at a higher percentage than the other disorders. The high 
percentage of sensory disturbance may worth to look into more details and study as the 
other shoulder disorders did not show this pattern very often. We did not find further 
explanation or reason behind this pattern in the literature.    
 
The precise location of pain is important in orthopaedics but does not always correlate 
with the site of pathology (Rodowsky & Bigliani, 1997). Despite the explanation that pain 
arising in deeper structures is more diffuse and sometimes has an unexpected distribution 
(Apley & Solomon, 1993), this needs to be highlighted and may require further 
explanation. 
 
The other shoulder problem, GHJ arthritis pain had the most widespread distribution 
among all diagnoses despite the limitation of the study due to the very limited number of 
the patients with GHJ arthritis. The issue related to widespread distribution of GHJ 
arthritis was discuss further as below in pain maps section.  
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Sensitivity, Specificity, Reliability and Algorithm: 
 
The second study showed high sensitivity and specificity for the disease groups. 
Sensitivity implies the proportion of the patients with the disease, whose tests are positive 
and specificity implies the probability that the patients does not have the disease when 
they are disease free (Faragher, 2005). There is no general agreement on what the 
acceptable levels of sensitivity and specificity for an assessment test are. Acceptable levels 
vary depending upon the intent of the test (Methodology tables, 2002). There were some 
previous studies with assessment of pain mapping for example back pain mapping by Pang 
et al. (1998) but they did not assess the sensitivities and specificities. So far, there were no 
other sensitivity and specificity studies on patients’ subjective experience of shoulder pain 
or pain map as diagnostic tool in the literature, Therefore, there was no other study for 
comparison.  
 
However, the literature described sensitivities and specificities for different clinical tests in 
the assessment of shoulder disorders as objective findings. Comparing to the meta-analysis 
of objective physical tests’ results, we believe that our sensitivity and specificity results 
from subjective patients’ experience to the diagnoses of pathology were generally 
acceptable. A meta-analysis showed the sensitivity and specificity of Neer test for 
impingement syndrome was 79% and 53%, respectively, and for the Hawkins-Kennedy 
test was 79% and 59%, respectively (Hegedus et al., 2008), whilst another study showed 
the sensitivity decreased to 40.3% when four tests of impingement syndrome were 
simultaneously positive, the specificity for the diagnosis was 98.5% (Fodor, Poanta, Felea, 
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Rednic, & Bolosiu 2009). In the current study, with self-completed patient mapping 
questionnaire, the sensitivity was high, and nearly as valuable as the other clinical tests 
(sensitivity 67.4%, the specificity 93.2%). 
The clinical tests for superior labral antero-posterior (SLAP) tears showed lower 
sensitivity and specificity of the Speed test; 32% and 61%, respectively (Hegedus et al., 
2008). In the current study, all the instability diseases (SLAP, Bankart’s, etc.) are grouped 
as one and the sensitivity and specificity of the clinical tests were relatively high. The 
sensitivity was between 0.65 and 0.81 whilst specificity was between 0.85 and 0.97.   
 
The low sensitivity (0.33) for rotator cuff pathology in the second step improved 
constantly after enhancing the pain map of this disorder. In the third step with testers, the 
sensitivity for rotator cuff was between 0.52 and 0.72. This means that the changes of 
pattern for rotator cuff pathology in the second phase were done correctly.   
 
The current study divided the shoulder maps marked by the patients into two main groups; 
1- pain localised to shoulder, 2- pain radiation beyond shoulder. Shoulder disorders were 
also classified as two main groups according to their pain patterns as above. The 
substantial agreement between map group and disease group in the second phase of the 
study means if anyone can estimate the group of the map using the shoulder pain mapping 
algorithm, they will match the group of the disease in over 80 % of cases. Estimating the 
disease group will narrow the number of the possibilities for the differential diagnoses and 
/ or at least it will give an idea on what the diagnosis could be. 
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In summary, the reports of the results in the current study showed very good agreement 
within the disease groups using the mapping algorithm. Although the current study was a 
unique study with its content and there were no comparable studies in the literature, the 
sensitivities and specificities in testing shoulder pain maps were comparable to clinical 
tests for some shoulder disorders especially for instability, but also good for impingement 
syndrome, rotator cuff pathology and ACJ pathology. Due to the low number of patients, it 
was difficult to comment on the patients with GHJ arthritis and calcific tendinitis despite 
some good results. The algorithm has been enhanced with testers’ advice. 
 
In the third phase, inter-tester reliability test was used to observe a score of how much 
consensus or homogeneity there was for the algorithm of the shoulder pain maps. There 
was substantial agreement between the testers for grouped diseases and specific diseases. 
Inter-tester reliability helps to understand the consistency of the raters estimates (Cherry, 
2013). The inter-tester reliability results in the third phase of the study with high 
agreement means there is consistent estimates of the algorithm and pain mapping system 
(Trochim, 2006). High agreement between the raters shows the clarity and the value of the 
algorithm and the established shoulder maps. 
 
In the literature search, most of the relevant intertester reliability studies were on spinal 
pain and there was one study on shoulder pain. Two of them were to test the classification 
systems in spine and shoulder pains. Shoulder pain study showed the kappa coefficient 
was 0.664 (Carter, Hall, McIntosh, Murphy, MacDougall, & Boyle, 2010), and spine pain 
classification showed (kappa = 0.61) (Wilson,  Hall,  McIntosh, & Melles, 1999). The 
comments for both studies were that their kappa coefficients denoted good reproducibility. 
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Comparing to the above studies, the current study showed even higher Kappa (κ) 
coefficient (0.71). 
 
The raters did not require long training or explanation, only a brief explanation. They 
commented that the algorithm and the colour-coded shoulder maps together were mostly 
self-explanatory. However, they also contributed to make further improvement in the 
algorithm, specifically on how to map the algorithm to assess the pins and needles or age 
distribution to ease the understanding of a third person. 
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Pain maps: 
 
The pain mappings for shoulder disorders in the current study were extensively studied 
along the three phases. They were established, tested, improved and described well for 
each (seven) shoulder condition accordingly in this unique study.  There were no previous 
studies on shoulder pain maps in the literature. 
 
The shoulder pain maps reflected the patients’ subjective experience, which can be 
considered as part of the history taking process. History taking was described as an art by 
(Rull & Draper, 2011). It is widely taught that diagnosis is revealed in the patient's history 
and sometimes it is all that is required to make the diagnosis. A well-designed visual pain 
map as in the current study’s example, may guide patients to express their symptoms in a 
more descriptive way and in return, this may help doctors diagnosing shoulder problems. 
However, they would not be enough themselves for full diagnosis. 
 
Pain maps have been found to be useful, for diagnostic, therapeutic, prognostic and 
research purposes (Palmer, 1949). Pain mapping has been previously described for neck, 
face, back and hip pain (Toomingas, 1999; Machacek & Friedrich, 2006; Turp, Kowalski, 
O`Leary, & Stohler, 1998). Pain maps were used for different applications. 
 
There were various anatomical divisions of the body on the pain maps in the literature. 
Turp (1998) mentioned up to 50 different regions or anatomical sites were distinguished  
or identified on the body maps in previously published studies.   In the current study, we 
used both front and back of the shoulder and arm with an extension towards neck (? Figure 
I). Although we described 14 cells on each side of the upper limb, for clinical and 
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diagnostic use, we divided the regions into only four in our descriptions; shoulder, down 
to elbow, below elbow area (forearm) and hand. The current study would not allow us to 
divide into more anatomical divisions as it would not be a practical approach for 
diagnostic purpose and would cause more conflict and confusion. 
 
All the patients in the current study marked their pain on upper limb region. Although our 
custom-made shoulder map did not include the whole body mapping and excluded the 
pain related to neck as part of exclusion criteria, there were no comments from the patients 
regarding radiation of the pain to a different region outside upper limb. Whereas in the 
study by Turp et al. (1998), shoulder pain was described very often by the facial pain 
patients; the majority of the patients (69%) in the study reported pain outside the face and 
their results also show the neck, shoulders, and upper back to be the most frequently 
involved areas. The current study excluded patients with neck pain in the beginning, prior 
to patient recruitment to avoid mixed picture of diagnoses and to isolate the origin of the 
pain for closer match to shoulder diagnoses. 
 
Shoulder pain maps may have a useful clinical role as an adjunct in the initial assessment 
of the shoulder problems as well as a research or follow-up tool. In any case, the definite 
diagnosis of shoulder problems could be very difficult despite the improvement in imaging 
technology. Symptoms and medical imaging may not correlate well (Carter et al., 2010) 
and investigations come with their cost. For example, ultrasound could be more cost-
effective in a specialist hospital setting for identification of full-thickness tears comparing 
to MRI scan (Dinnes et al., 2003).  Whilst cost effectiveness is important in investigating 
shoulder disorders, shoulder mapping can be an adjunct to the diagnosis. It can be 
particularly helpful in general practice. The practitioner, who may not have the expertise 
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in diagnosing the shoulder problems, may benefit more from the guidance of the pain 
mapping algorithm to prevent unnecessary investigations such as an MRI scan for ACJ 
pathology. 
 
The use of pain maps in different settings may have different interpretations. According to 
the North American Spine (2013), when nerve roots are compressed, the pain signals they 
generate can be felt in different areas throughout the body. The pain mapping system can 
be useful to isolate the origin of the pain. However, the experience of pain is personal and 
it can be different for each individual (Brain Injury, 1998). The patient's description of 
pain is important and this may guide clinicians towards diagnosing the disorders. 
 
There are some other studies which may give some ideas about how useful the pain maps 
could be. Machacek and Friedrich (2006) aimed to find out the reliability of several 
dermatomic maps (description of pain pattern within a nerve root lesion) according to the 
respective segmental area. They did not find a clear correlation between the pain 
projections of the lumbar spine. They concluded that the pain pattern of dermatomic maps 
is only of limited value for the definition of the affected segment. In a prospective study, 
however, Pang, Mok, Lin, Chang and Hwang (1998) examined and analysed 104 
consecutive adult patients who underwent spinal pain mapping.  They concluded that 
spinal pain mapping provided a useful functional approach to the diagnosis of low back 
pain with obscure aetiology in 87% of patients in their series. Likewise, when Wright 
(2000) conducted a study about referred craniofacial pain patterns in patients with 
temporomandibular disorder, he found that the pattern between referred pain source and 
site was consistent and predictable. As a result, all the studies above concluded that pain 
mapping is a useful and valuable tool for clinical assessment.   
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A different use of pain mapping was described for the human brain using functional 
magnetic resonance imaging (fMRI). It is suggested that pain maps could be used to 
determine the kind of pain which is felt by patients who are unable to articulate it (RT, 
2013). The pain maps could be used to provide markers for the location in the human brain 
and this would enable clinicians to understand how patients’ brain reorganise following 
chronic pain (Medicalxpress, 2012). In appropriate setting, questionnaires may give very 
useful information about disorders. For example, in the assessment of neck and upper 
extremity disorders, Ohlsson et al., (1994) concluded that the questionnaire approach gives 
a fairly good picture of the neck / upper extremity status of a working female population. 
Most subjects with findings on clinical examination of shoulders reported symptoms on 
the questionnaire (sensitivity 80%). 
 
Visual analogue scales (VAS) was a part of the mapping questionnaire in the current study 
and it was used to compare the severity of pain. The VAS scales create ratio level data that 
is more easily comparable (Disorbio & Bruns, 1999). Although its value is limited by the 
previous lack of a standardized method for performing such a rating, or any scientifically-
based norms for making comparisons, the 0-10 pain scale had benefit from an extremely 
broad acceptance in the field (Disorbio & Bruns, 1999). 
 
 Toomingas (1999) looked at subjects with chronic and severe pain and correlated this 
with pain drawings. Patients with more chronic or severe pain symptoms had pain 
drawings that occupied a larger area. As suggested above, our study also showed the same 
correlation existence between the severity of pain and area of radiation. The most severe 
pain was in GHJ arthritis patients, who marked a mean of 12.5 out of 28 cells on the pain 
map, which was the greatest number amongst all groups. Moreover, the ACJ pathology 
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was the most pinpoint described one and the average of area marked by the patients was 
only 3.9 with the least severe pain of 6.43 on VAS. 
 
In the current study, pain patterns were constant and very predictable for the disease 
groups (1 and 2) as well as showing good results for individual shoulder diseases 
especially instability, ACJ pathology and impingement. The substantial agreement 
between the raters shows the reliability of the algorithm and colour-coded shoulder pain 
maps. 
 
This is the first study to describe the usage of pain maps in the shoulder and a unique 
study with its three phases. There was no previous study on any of the three phases of 
shoulder pain maps. In the literature, the studies on pain maps of face, hip or back were 
with evidence level of four but not blinded and no review studies. In the current study, a 
definitive pattern of pain distribution and specific types of pain in common shoulder 
pathologies has been demonstrated. One advantage of the shoulder mapping could be that 
the patients might complete the questionnaire before the clinic visit and the clinician 
would have an idea about the problem before seeing the patient. It is simpler to understand 
and easier to complete as a visual questionnaire and possibly more advantageous over the 
written one.  
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Limitation: 
 
In an inter-observer agreement study for classification of shoulder disorders,   de Winter et 
al. (1999) concluded that differentiation between the various categories of shoulder 
disorders is complicated. The number of the disorders (seven) and different types of pain 
(four) meant too many variables and made the study more difficult for statistical approach.  
 
This led to ‘hand analysis’ of disorder patterns directly from the excel sheet.  Additionally, 
the small number of patients with some diagnosis such as GHJ arthritis and calcific 
tendinitis was another limitation of the study related to analysis of those disorders. 
Therefore, it caused a problem with testing of the pain mapping, although this could be a 
reflection of frequency of the disorders in the population. 
 
Larger sample size would give further accuracy in shoulder pain mapping especially for 
GHJ arthritis and calcific tendinitis. However, the study was blinded study in terms of 
diagnoses. The number of the groups and the number of the patients in each group were 
not known before obtaining final diagnoses for the included patients. Therefore, sample 
size was not calculated prior to the phase one and two. In addition to six diagnoses in the 
first phase of the study, another diagnosis was added (frozen shoulder) in the second phase 
after obtaining the final diagnoses.  But post-hoc calculations were performed for the 
results with statistically significant findings.  
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Further exclusion of the patients in the second phase was a major limitation to the study 
and this possibly contributed to the low number the above diagnoses.      Despite the initial 
inclusion and exclusion criteria, many patients (128) were excluded from the second phase 
of the study at a later stage. Some of these exclusions were secondary to patients 
misinterpreting how to mark the custom-made shoulder map form despite verbal 
explanations. Whenever possible, we included the maps to the study but we did not want 
to cause bias. Therefore, we excluded the unacceptable maps. The other major reason for 
exclusion despite initial inclusion was inadequate clinical data. This probably was due to 
patients been lost to follow up or drop out. Drop outs maybe led to inadequate clinical 
information of those patients for accurate diagnoses. Therefore, they were excluded from 
the study. In turn, this decreased the number of the patients affected the sample size. 
 
Testing the color-coded shoulder pain maps showed better results for ACJ and instability 
in the second phase, however, the results showed that it was not very good for rotator cuff 
pathology. This was probably due to the similar pain patterns of two or three disorders. 
After the necessary changes to its pattern at the end of phase two, the third phase showed 
better results. A similarity in some pain patterns of shoulder disorders was another 
limitation to define precise pain maps for shoulder disorders. This led to classify the pain 
patterns into groups and subgroups according to their similarities.   
 
Although the study was conducted in different hospitals and it was tested by three 
different raters in addition to the researcher, multi-centre studies might lead to better 
generalisation. 
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The study aimed to perform a quantitative study about shoulder pain mapping. An addition 
of qualitative assessment to the study about pain perception of the patients would increase 
the strength of the study and potentially give a better picture of pain patterns. However, 
this will probably mean further extension of the study. It could be beyond the scope the 
current study. 
 
The other limitation was misinterpretation of the pain maps by the patients although the 
map itself was very explanatory and simple, and the patients were explained the map 
before they marked them, there were still some mismarked maps. 
 
No age limit was planned and it showed massive age ranges. The clinic included all the 
adult population with shoulder problems. For example GHJ arthritis, ACL pathologies are 
commoner in older patients, whereas instability is commoner is younger patients. If we 
limit the age, we would miss a variety of the diseases and the number of the patients 
included in the study would be less.   
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Conclusion: 
 
The authors of the study advocate the use of pain maps as a diagnostic tool in shoulder 
clinics and this can also be very helpful in the primary care setting. Although shoulder 
mapping itself is insufficient for precise clinical diagnosis, it can be valuable as an adjunct 
to the other assessments and play an important role in shoulder disorders 
 
This is a unique study with its content and conclusion. There was no other previous study 
to compare the results with. We believe that this study will fill the gap for the patient 
assessment from the patient subjective experience to shoulder pathology.   
 
This is the first study to describe the use of pain maps in the shoulder. A definitive pattern 
of pain distribution and specific types of pain in common shoulder pathologies has been 
demonstrated. The study may further suggest that accurate history from patients about 
their symptoms and pain distribution may give important clues about their diagnosis and 
may potentially prevent unnecessary investigations. 
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Further Use:  
 
It can be remotely used as online - computer tools for the patients self assessments, or as 
pre-attendance to clinics, which may help the clinician have an idea about the shoulder 
problem when the maps are utilised with the algorithm. 
 
 
The use of pain maps could be further expanded as a diagnostic aid in patients with 
combined neck and shoulder pathology and multiple shoulder pathologies. It may lead to 
further studies for example, combination of shoulder mapping with psychological 
assessment tools to convey the recognition of an additional psychological approach. 
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shoulder* 
AND 
Disease* OR Disorder* 
AND 
Pain* 
AND 
Map* OR Draw* OR Pattern* 
Table -1: Search Terms 
 
 
Literature Search Results of Databases 
 
1-) The Cochrane Library: 09/12/2013  via the Wiley Online Library (repeat search) 
http://onlinelibrary.wiley.com/cochranelibrary/search  
Cochrane Database of Systematic Reviews : Issue 12 of 12, December 2013 
There are 58 results from 8219 records for your search on 'shoulder 
pain’ in Title, Abstract, Keywords in Cochrane Reviews' 
 
Cochrane Central Register of Controlled Trials : Issue 11 of 12, November 2013 
There are 34 results from 717246 records for your search on 'shoulder 
pain pattern’ in Title, Abstract, Keywords in Trials' 
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2- MEDLINE  (from 1950 to 04/12/2013) via NHS Evidence (www.library.nhs.uk)  
No.             Search term Hits 
1 MEDLINE exp SHOULDER/ 8872  
2 MEDLINE shoulder.ti,ab 41588  
3 MEDLINE 1 OR 2 44979  
4 MEDLINE 
exp PAIN/ OR exp 
SHOULDER PAIN/ 
310095  
5 MEDLINE pain.ti,ab 408320  
6 MEDLINE 4 OR 5 547510  
7 MEDLINE disorder*.ti,ab 742827  
8 MEDLINE exp DISEASE/ 117746  
9 MEDLINE disease*.ti,ab 2570479  
10 MEDLINE 7 OR 8 OR 9 3184337  
11 MEDLINE map*.ti,ab 335803  
12 MEDLINE pattern*.ti,ab 936017  
13 MEDLINE draw*.ti,ab 136400  
14 MEDLINE 11 OR 12 OR 13 1362958  
15 MEDLINE 3 AND 10 6112  
16 MEDLINE 6 AND 14 23918  
17 MEDLINE 15 AND 16 184  
18 MEDLINE Duplicate filtered: [15 AND 16] 
184 171 Unique results 13 
Duplicate results  
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3- EMBASE   (from 1980 to 04/12/2013) via NHS Evidence (www.library.nhs.uk)  
No.             Search term Hits 
 
1 EMBASE exp SHOULDER/ 21574  
2 EMBASE shoulder.ti,ab 48471  
3 EMBASE 1 OR 2 54612  
4 EMBASE disorder*.ti,ab 897555  
5 EMBASE disease*.ti,ab 3064527  
6 EMBASE 4 OR 5 3695788  
7 EMBASE 
exp LIMB PAIN/ OR exp PAIN/ OR 
exp PAIN ASSESSMENT/ OR exp 
SHOULDER PAIN/ 
796051  
8 EMBASE pain*.ti,ab 587424  
9 EMBASE 7 OR 8 1007646  
10 EMBASE map*.ti,ab 350312  
11 EMBASE pattern*.ti,ab 990572  
12 EMBASE exp DRAWING/ 2091  
13 EMBASE draw*.ti,ab 158650  
14 EMBASE 10 OR 11 OR 12 OR 13 1451949  
15 EMBASE 3 AND 6 7841  
16 EMBASE 9 AND 14 42440  
17 EMBASE 15 AND 16 276  
18 EMBASE Duplicate filtered: [15 AND 16] 
276 265 Unique 
results 11 
Duplicate results  
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CINAHL  (from 1981 to 04/12/2013) via NHS Evidence (www.library.nhs.uk)  
No.            Search term                     Hits  
 
1 CINAHL exp SHOULDER/ 3130  
2 CINAHL shoulder.ti,ab 9223  
3 CINAHL exp DISEASE/ 76292  
4 CINAHL disease*.ti,ab 200778  
5 CINAHL disorder*.ti,ab 77565  
6 CINAHL 1 OR 2 10173  
7 CINAHL 3 OR 4 OR 5 324229  
8 CINAHL exp PAIN/ 90189  
9 CINAHL pain*.ti,ab 94255  
10 CINAHL 8 OR 9 129047  
11 CINAHL exp MAPS/ 1447  
12 CINAHL map*.ti,ab 11228  
13 CINAHL pattern*.ti,ab 53773  
14 CINAHL draw*.ti,ab 22274  
15 CINAHL 
11 OR 12 OR 13 
OR 14 
86083  
16 CINAHL 6 AND 7 1601  
17 CINAHL 10 AND 15 5011  
18 CINAHL 16 AND 17 49  
19 CINAHL 
Duplicate filtered: 
[16 AND 17] 
49 49 Unique results 0 Duplicate results  
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    Figure I: The sample map to be marked by the patients (excluding the red and  
    green marks: they were only used on comparison sheet.)  
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The  Colour-coded Pain Maps for Common Shoulder Disorders 
 
 
 
 
 
 
   Colour coding of pain 
 
 
 
  Sharp/shooting/stabbing pain 
 
 
   Dull and/or aching pain 
 
                            
                                         Numbness and/or pinds&needles 
 
 
 
                                         Mixture of dull and sharp pain  
 
 
   Burning pain 
 
 
 
 
 
 
    (Bayam et al, 2011) 
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       Figure 1: ACJ pathology 
        
 
 
      
 
 
 
 
 
 
 
 
 
 
       Figure 2: Instability 
 
 
 
 
        
 
 
 
 
 
 
  
  
 
       Figure 3: Calcific tendinitis 
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   4a 
 
 
 
 
 
 
 
 
 
 
  4b 
 
 
       Figure 4a and 4b: Rotator cuff tear (the upper one- 4a is from the first phase 
                                                                 The lower one- 4b is from the second phase) 
 
 
 
 
 
  
    
 
 
       Figure 5: Frozen Shoulder 
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       Figure 6: Impingement 
 
 
 
 
 
 
       
        
 
 
 
 
 
 
 
 
 
      Figure 7:  GHJ Artritis 
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Shoulder Pain Mapping Algorithm 
 
 
The extension of the marked area of pain from less to more (the numbers shows the 
disorder codes): 
 
1 <  2  <  3  <  4  <  5  <  6  <  7 
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How to Read the Map: 
1- Initially, the shoulder disorders are divided into two main group from map point of 
view:  
First group: The ones with the pain around only shoulder (ACJ path, Instability, Calc 
Tendinitis), limited radiation of pain beyond shoulder 
Second group: the ones with the pain radiates beyond the shoulder (Rotator cuff tear, 
Frozen Shoulder, Impingement, GHJ arthritis).  
2- First step is to look if marking finishes above, below or around elbow – ignore the 
numbness around hand and wrist 
          Around Shoulder, above elbow: ACJ pathology(Code-1), Instability (Code-2), 
Calcific tendinitis (Code-3) 
                The extension of the marked area of pain from less to more (the numbers shows 
the disorder codes): 
 
                  1 <  2  <  3   
3-         A-  Small area of  predominantly sharp pain, maybe some dull pain ACJ 
(Code-1) 
4-         B-  Larger area of mixture of sharp and dull pain  instability (Code-2) 
5-              If any indecisiveness between  instability and ACJ pathology, if  age  <40 
most probably instability and >40  most probably ACJ pathology  
6-         C- Larger area, but predominantly sharp pain  Calcific tendinitis(Code-3) 
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7-  The second group is subdivided into: 
                I- Around arm down to elbow level: D-rotator cuff tear (Code-4), E-frozen 
shoulder (code-5) 
          II- Below elbow level: F- Impingement (Code-6), G-GHJ arthritis (Code-7) 
         
8-         D- Sharp proximally and radiating as dull pain distally rotator cuff (Code-4) 
9-         E- Characterized with sharp or mixed pattern proximally and dull pain more 
distally  Frozen shoulder (Code-5) 
10-   The extension of the marked area of pain from less to more (the numbers shows the 
disorder codes): 
                  4  <  5   
11- The disorders that the marking goes beyond elbow 
12-         F- Sharp pain proximally and dull pain distally with wrist-hand numbness  
Impingement (Code-6) 
13-         G- Predominantly sharp, widespread pain  GHJ arthritis (Code- 7) 
14- The extension of the marked area of pain from less to more (the numbers shows the 
disorder codes): 
 
                   6  <  7 
15- The extension of the marked area of pain from less to more (the numbers shows the 
disorder codes): 
 
1 <  2  <  3  <  4  <  5  <  6  <  7 
Or 
A < B < C < D < E < F < G 
 
 
 
                                                                                                          Levent Bayam @00279526    
139 
 
Full Statistics reports of the first phase 
 
ONEWAY Painseverity Areano BY Diagnosis 
  /STATISTICS DESCRIPTIVES HOMOGENEITY 
  /PLOT MEANS 
  /MISSING ANALYSIS 
  /POSTHOC=TUKEY ALPHA(0.05). 
 
 
 
Oneway 
 
 
[DataSet1] G:\wrightington start\shoulder mapping\shoulder SPSS.sav 
 
 
 
 
Descriptives 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence Interval 
for Mean 
Minimu
m 
  
Lower 
Bound 
Upper 
Bound 
Severity of Pain impingement 2
7 
7.518
5 
1.80534 .34744 6.8043 8.2327 3.00 
rotator cuff tear 2
2 
7.045
5 
1.46311 .31194 6.3967 7.6942 5.00 
G. Arthritis 
6 
7.833
3 
1.94079 .79232 5.7966 9.8701 5.00 
Instability 1
8 
6.722
2 
1.80866 .42630 5.8228 7.6216 3.00 
ACJ pathology 1
4 
6.428
6 
1.74154 .46545 5.4230 7.4341 2.00 
Calcific 
tendinitis 
6 
7.500
0 
2.42899 .99163 4.9509 10.0491 3.00 
Total 9
3 
7.107
5 
1.77826 .18440 6.7413 7.4738 2.00 
Number of the 
areas 
impingement 2
8 
7.214
3 
3.83316 .72440 5.7279 8.7006 1.00 
rotator cuff tear 2
2 
5.590
9 
3.37581 .71973 4.0942 7.0877 1.00 
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G. Arthritis 
6 
12.50
00 
8.52643 3.48090 3.5521 21.4479 4.00 
Instability 1
7 
6.882
4 
6.17335 1.49726 3.7083 10.0564 1.00 
ACJ pathology 1
4 
3.857
1 
1.91581 .51202 2.7510 4.9633 2.00 
Calcific 
tendinitis 
6 
5.500
0 
4.03733 1.64823 1.2631 9.7369 2.00 
Total 9
3 
6.494
6 
4.76998 .49462 5.5123 7.4770 1.00 
Multiple Comparisons 
Tukey HSD 
       
Dependent 
Variable 
(I) shoulder 
diseases 
(J) shoulder 
diseases 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Severity of Pain impingement rotator cuff tear 
.47306 .50884 
.93
8 
-1.0098 
1.955
9 
G. Arthritis 
-.31481 .79960 
.99
9 
-2.6450 
2.015
4 
Instability 
.79630 .53909 
.68
0 
-.7747 
2.367
3 
ACJ pathology 
1.08995 .58347 
.42
9 
-.6104 
2.790
3 
Calcific 
tendinitis 
.01852 .79960 
1.0
00 
-2.3117 
2.348
7 
rotator cuff tear impingement 
-.47306 .50884 
.93
8 
-1.9559 
1.009
8 
G. Arthritis 
-.78788 .81596 
.92
8 
-3.1658 
1.590
0 
Instability 
.32323 .56306 
.99
2 
-1.3177 
1.964
1 
ACJ pathology 
.61688 .60569 
.91
1 
-1.1482 
2.382
0 
Calcific 
tendinitis 
-.45455 .81596 
.99
3 
-2.8324 
1.923
3 
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G. Arthritis impingement 
.31481 .79960 
.99
9 
-2.0154 
2.645
0 
rotator cuff tear 
.78788 .81596 
.92
8 
-1.5900 
3.165
8 
Instability 
1.11111 .83516 
.76
7 
-1.3227 
3.544
9 
ACJ pathology 
1.40476 .86447 
.58
4 
-1.1145 
3.924
0 
Calcific 
tendinitis 
.33333 1.02286 
.99
9 
-2.6475 
3.314
2 
Instability impingement 
-.79630 .53909 
.68
0 
-2.3673 .7747 
rotator cuff tear 
-.32323 .56306 
.99
2 
-1.9641 
1.317
7 
G. Arthritis 
-1.11111 .83516 
.76
7 
-3.5449 
1.322
7 
ACJ pathology 
.29365 .63132 
.99
7 
-1.5462 
2.133
5 
Calcific 
tendinitis 
-.77778 .83516 
.93
7 
-3.2116 
1.656
1 
ACJ pathology impingement 
-1.08995 .58347 
.42
9 
-2.7903 .6104 
rotator cuff tear 
-.61688 .60569 
.91
1 
-2.3820 
1.148
2 
G. Arthritis 
-1.40476 .86447 
.58
4 
-3.9240 
1.114
5 
Instability 
-.29365 .63132 
.99
7 
-2.1335 
1.546
2 
Calcific 
tendinitis 
-1.07143 .86447 
.81
6 
-3.5907 
1.447
8 
Calcific 
tendinitis 
impingement 
-.01852 .79960 
1.0
00 
-2.3487 
2.311
7 
rotator cuff tear 
.45455 .81596 
.99
3 
-1.9233 
2.832
4 
G. Arthritis 
-.33333 1.02286 
.99
9 
-3.3142 
2.647
5 
Instability 
.77778 .83516 
.93
7 
-1.6561 
3.211
6 
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ACJ pathology 
1.07143 .86447 
.81
6 
-1.4478 
3.590
7 
Number of the 
areas 
impingement rotator cuff tear 
1.62338 1.27357 
.79
8 
-2.0881 
5.334
8 
G. Arthritis 
-5.28571 2.01101 
.10
1 
-
11.1462 
.5748 
Instability 
.33193 1.37446 
1.0
00 
-3.6735 
4.337
4 
ACJ pathology 
3.35714 1.46322 
.20
8 
-.9070 
7.621
3 
Calcific 
tendinitis 
1.71429 2.01101 
.95
7 
-4.1462 
7.574
8 
rotator cuff tear impingement 
-1.62338 1.27357 
.79
8 
-5.3348 
2.088
1 
G. Arthritis 
-6.90909
*
 2.05883 
.01
4 
-
12.9090 
-.9092 
Instability 
-1.29144 1.44353 
.94
7 
-5.4982 
2.915
3 
ACJ pathology 
1.73377 1.52829 
.86
6 
-2.7200 
6.187
5 
Calcific 
tendinitis 
.09091 2.05883 
1.0
00 
-5.9090 
6.090
8 
G. Arthritis impingement 
5.28571 2.01101 
.10
1 
-.5748 
11.14
62 
rotator cuff tear 
6.90909
*
 2.05883 
.01
4 
.9092 
12.90
90 
Instability 
5.61765 2.12272 
.09
7 
-.5684 
11.80
37 
ACJ pathology 
8.64286
*
 2.18125 
.00
2 
2.2863 
14.99
95 
Calcific 
tendinitis 
7.00000 2.58088 
.08
3 
-.5212 
14.52
12 
Instability impingement 
-.33193 1.37446 
1.0
00 
-4.3374 
3.673
5 
rotator cuff tear 
1.29144 1.44353 
.94
7 
-2.9153 
5.498
2 
G. Arthritis 
-5.61765 2.12272 
.09
7 
-
11.8037 
.5684 
ACJ pathology 
3.02521 1.61332 
.42
4 
-1.6764 
7.726
8 
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Test of Homogeneity of Variances 
 
Levene Statistic df1 df2 Sig. 
Severity of Pain .393 5 87 .853 
Number of the areas 3.384 5 87 .008 
 
 
ANOVA 
  
Sum of 
Squares df 
Mean 
Square F Sig. 
Severity of Pain Between Groups 17.856 5 3.571 1.138 .347 
Within Groups 273.068 87 3.139 
  
Total 290.925 92 
   
Calcific 
tendinitis 
1.38235 2.12272 
.98
7 
-4.8037 
7.568
4 
ACJ pathology impingement 
-3.35714 1.46322 
.20
8 
-7.6213 .9070 
rotator cuff tear 
-1.73377 1.52829 
.86
6 
-6.1875 
2.720
0 
G. Arthritis 
-8.64286
*
 2.18125 
.00
2 
-
14.9995 
-
2.286
3 
Instability 
-3.02521 1.61332 
.42
4 
-7.7268 
1.676
4 
Calcific 
tendinitis 
-1.64286 2.18125 
.97
4 
-7.9995 
4.713
7 
Calcific 
tendinitis 
impingement 
-1.71429 2.01101 
.95
7 
-7.5748 
4.146
2 
rotator cuff tear 
-.09091 2.05883 
1.0
00 
-6.0908 
5.909
0 
G. Arthritis 
-7.00000 2.58088 
.08
3 
-
14.5212 
.5212 
Instability 
-1.38235 2.12272 
.98
7 
-7.5684 
4.803
7 
ACJ pathology 
1.64286 2.18125 
.97
4 
-4.7137 
7.999
5 
*. The mean difference is significant at the 0.05 level. 
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Number of the areas Between Groups 354.736 5 70.947 3.550 .006 
Within Groups 1738.511 87 19.983 
  
Total 2093.247 92 
   
 
 
 
 
Homogeneous Subsets 
 
 
Severity of Pain 
Tukey HSD 
  
shoulder diseases N 
Subset for alpha 
= 0.05 
1 
ACJ pathology 14 6.4286 
Instability 18 6.7222 
rotator cuff tear 22 7.0455 
Calcific tendinitis 6 7.5000 
impingement 27 7.5185 
G. Arthritis 6 7.8333 
Sig. 
 
.431 
Means for groups in homogeneous subsets are displayed. 
 
 
Number of the areas 
Tukey HSD 
   
shoulder diseases N 
Subset for alpha = 0.05 
1 2 
ACJ pathology 14 3.8571 
 
Calcific tendinitis 6 5.5000 
 
rotator cuff tear 22 5.5909 
 
Instability 17 6.8824 
 
impingement 28 7.2143 7.2143 
G. Arthritis 6 
 
12.5000 
Sig. 
 
.495 .071 
Means for groups in homogeneous subsets are displayed. 
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F         3.550 
 
,  F(2, 128) = 13.733, p= .001,  ç
p
2
= .177 
 
F (5, 87)= 3.550, p=0.006  showed significant difference between the number of the areas 
marked by the patients. On post hoc tests after finding a significant p value, tukey test was 
performed and p was  > 0.05(0.495) showing the homogeneity of the groups for the 
number of the areas 
 
 
 
Number of the areas 
Tukey HSD 
   
shoulder diseases N 
Subset for alpha = 0.05 
1 2 
ACJ pathology 14 3.8571 
 
Calcific tendinitis 6 5.5000 
 
rotator cuff tear 22 5.5909 
 
Instability 17 6.8824 
 
impingement 28 7.2143 7.2143 
G. Arthritis 6 
 
12.5000 
Sig. 
 
.495 .071 
Means for groups in homogeneous subsets are displayed. 
 
 
 
 
 
ANOVA 
  
Sum of 
Squares df Mean Square F Sig. 
Severity of Pain Between Groups 17.856 5 3.571 1.138 .347 
Within Groups 273.068 87 3.139 
  
Total 290.925 92 
   
Number of the areas Between Groups 
354.736 5 70.947 3.550 .006 
Within Groups 1738.511 87 19.983 
  
Total 2093.247 92 
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Post hoc Multiple comparisons showed meaningful difference especially between G arthritis and rotator cuff 
tears (p= 0.014) and between G arthritis  and ACJ pathology (p= 0.002) 
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Statistics Reports of the Second Phase 
 
Second phase: Agreement of estimation and diagnosis 
Crosstabs   
 
Row variable (first classifier): Overal best-L 
Column variable (second classifier): Actual 
 
 1 2 3 4 5 6 7  
1 26 3 0 7 0 6 0  
2 0 51 2 7 2 3 0  
3 1 1 5 1 2 1 0  
4 1 5 0 9 2 0 1  
5 2 2 0 2 0 5 0  
6 0 7 0 0 3 31 0  
7 0 1 0 1 2 0 2  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 63.92% 
Expected agreement = 22.31% 
Kappa = 0.535536 (se = 0.035833) 
95% confidence interval = 0.465305 to 0.605766 
z (for k = 0) = 14.945507 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0.8333 0.6667 0.5 0.3333 0.1667 0  
0.8333 1 0.8333 0.6667 0.5 0.3333 0.1667  
0.6667 0.8333 1 0.8333 0.6667 0.5 0.3333  
0.5 0.6667 0.8333 1 0.8333 0.6667 0.5  
0.3333 0.5 0.6667 0.8333 1 0.8333 0.6667  
0.1667 0.3333 0.5 0.6667 0.8333 1 0.8333  
0 0.1667 0.3333 0.5 0.6667 0.8333 1  
Observed agreement = 84.45% 
Expected agreement = 64.46% 
Kappa = 0.562519 (se = 0.052614) 
95% confidence interval for kappa = 0.459398 to 0.66564 
z (for kw = 0) = 10.691495 
P < 0.0001 
 
Scott's pi 
Observed agreement = 63.92% 
Expected agreement = 22.51% 
Pi = 0.534341 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 12.385919  df = 6  P = 0.0539 
 
Symmetry (generalised McNemar) chi-square = 26.266667  df = 21  P = 0.1965 
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Second Phase: Sensitivity, specificity 
Disease- 1 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Tue Oct 8 21:25:52 UTC+0100 2013) 
Values entered: 
 
Condition 
Totals   Absent  Present 
 Test Positive  4 26 30 
 Test Negative  148 16 164 
 Totals  152 42 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.216495 0.162062 0.28242 
Sensitivity 0.619048 0.456502 0.760097 
Specificity 0.973684 0.929772 0.991537 
For any particular test result, the probability that it will be: 
Positive 0.154639 0.108328 0.215029 
Negative 0.845361 0.784971 0.891672 
For any particular positive test result, the probability that it is: 
True Positive 0.866667 0.683577 0.956403 
False Positive 0.133333 0.043597 0.316423 
For any particular negative test result, the probability that it is: 
True Negative 0.902439 0.843832 0.941427 
False Negative 0.097561 0.058573 0.156168 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 23.52381 8.691416 63.66852 
Negative [C] 0.391248 0.265994 0.575485 
Positive [W] 6.5 2.582498 16.360131 
Negative [W] 0.108108 0.067787 0.172414 
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Disease-2 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Tue Oct 8 21:29:11 UTC+0100 2013) 
Values entered: 
 
Condition 
Totals   Absent  Present 
 Test Positive  19 51 70 
 Test Negative  110 14 124 
 Totals  129 65 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.335052 0.270002 0.406753 
Sensitivity 0.784615 0.661922 0.8732 
Specificity 0.852713 0.777006 0.906764 
For any particular test result, the probability that it will be: 
Positive 0.360825 0.29413 0.433128 
Negative 0.639175 0.566872 0.70587 
For any particular positive test result, the probability that it is: 
True Positive 0.728571 0.607013 0.824771 
False Positive 0.271429 0.175229 0.392987 
For any particular negative test result, the probability that it is: 
True Negative 0.887097 0.814674 0.934634 
False Negative 0.112903 0.065366 0.185326 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 5.327126 3.450437 8.224542 
Negative [C] 0.252587 0.158403 0.402774 
Positive [W] 2.684211 1.782142 4.04288 
Negative [W] 0.127273 0.077553 0.208869 
 
 
                                                                                                          Levent Bayam @00279526    
150 
 
 
Disease-3 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Tue Oct 8 21:31:24 UTC+0100 2013) 
Values entered: 
 
Condition 
Totals   Absent  Present 
 Test Positive  2 5 7 
 Test Negative  182 5 187 
 Totals  184 10 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.051546 0.026406 0.095476 
Sensitivity 0.5 0.201423 0.798577 
Specificity 0.98913 0.957152 0.998115 
For any particular test result, the probability that it will be: 
Positive 0.036082 0.015902 0.075935 
Negative 0.963918 0.924065 0.984098 
For any particular positive test result, the probability that it is: 
True Positive 0.714286 0.302561 0.948876 
False Positive 0.285714 0.051124 0.697439 
For any particular negative test result, the probability that it is: 
True Negative 0.973262 0.935341 0.990115 
False Negative 0.026738 0.009885 0.064659 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 46 10.148789 208.497789 
Negative [C] 0.505495 0.271952 0.939594 
Positive [W] 2.5 0.708052 8.827039 
Negative [W] 0.027473 0.011567 0.065248 
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Disease-4 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Tue Oct 8 21:53:14 UTC+0100 2013) 
Values entered: 
 
Condition 
Totals   Absent  Present 
 Test Positive  8 9 17 
 Test Negative  159 18 177 
 Totals  167 27 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.139175 0.095283 0.197807 
Sensitivity 0.333333 0.172353 0.539849 
Specificity 0.952096 0.904533 0.977555 
For any particular test result, the probability that it will be: 
Positive 0.087629 0.053411 0.138867 
Negative 0.912371 0.861133 0.946589 
For any particular positive test result, the probability that it is: 
True Positive 0.529412 0.285339 0.761427 
False Positive 0.470588 0.238573 0.714661 
For any particular negative test result, the probability that it is: 
True Negative 0.898305 0.841706 0.936939 
False Negative 0.101695 0.063061 0.158294 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 6.958333 2.940863 16.464012 
Negative [C] 0.70021 0.535967 0.914783 
Positive [W] 1.125 0.573035 2.208633 
Negative [W] 0.113208 0.072975 0.17562 
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Disease –6 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Tue Oct 8 21:56:48 UTC+0100 2013) 
Values entered: 
 
Condition 
Totals   Absent  Present 
 Test Positive  10 31 41 
 Test Negative  138 15 153 
 Totals  148 46 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.237113 0.180425 0.304445 
Sensitivity 0.673913 0.518654 0.800308 
Specificity 0.932432 0.875946 0.965298 
For any particular test result, the probability that it will be: 
Positive 0.21134 0.157503 0.276882 
Negative 0.78866 0.723118 0.842497 
For any particular positive test result, the probability that it is: 
True Positive 0.756098 0.593558 0.870922 
False Positive 0.243902 0.129078 0.406442 
For any particular negative test result, the probability that it is: 
True Negative 0.901961 0.840707 0.942205 
False Negative 0.098039 0.057795 0.159293 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 9.973913 5.304884 18.75233 
Negative [C] 0.349716 0.23061 0.53034 
Positive [W] 3.1 1.759661 5.461281 
Negative [W] 0.108696 0.067124 0.176013 
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Disease -7 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Tue Oct 8 21:58:30 UTC+0100 2013) 
Values entered: 
 
Condition 
Totals   Absent  Present 
 Test Positive  1 2 3 
 Test Negative  187 4 191 
 Totals  188 6 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.030928 0.012634 0.069224 
Sensitivity 0.333333 0.05999 0.758921 
Specificity 0.994681 0.966183 0.999722 
For any particular test result, the probability that it will be: 
Positive 0.015464 0.004002 0.048173 
Negative 0.984536 0.951827 0.995998 
For any particular positive test result, the probability that it is: 
True Positive 0.666667 0.125335 0.982347 
False Positive 0.333333 0.017653 0.874665 
For any particular negative test result, the probability that it is: 
True Negative 0.979058 0.94377 0.99327 
False Negative 0.020942 0.00673 0.05623 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 62.666667 6.548144 599.728909 
Negative [C] 0.670232 0.38061 1.180238 
Positive [W] 2 0.334191 11.969212 
Negative [W] 0.02139 0.00811 0.05642 
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Second Phase: Disease group- Map Group Agreement 
 
Crosstabs   
 
Row variable (first classifier): Disease group 
Column variable (second classifier): map group 
 
 1 2  
1 71 22  
2 13 88  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 81.96% 
Expected agreement = 50.28% 
Kappa = 0.63717 (se = 0.071483) 
95% confidence interval = 0.497067 to 0.777273 
z (for k = 0) = 8.913632 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0  
0 1  
Observed agreement = 81.96% 
Expected agreement = 50.28% 
Kappa = 0.63717 (se = 0.071483) 
95% confidence interval for kappa = 0.497067 to 0.777273 
z (for kw = 0) = 8.913632 
P < 0.0001 
 
Scott's pi 
Observed agreement = 81.96% 
Expected agreement = 50.38% 
Pi = 0.636383 
95% Donner-Eliasziw confidence interval = 0.515375 to 0.732535 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 2.314286  df = 1  P = 0.1282 
 
Symmetry (generalised McNemar) chi-square = 2.314286  df = 1  P = 0.1282 
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Second Phase: Group Estimation – Sensitivity, Specificity 
For Group-1 Shoulder Disease: 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Tue Oct 8 21:18:00 UTC+0100 2013) 
Values entered: 
 
Condition 
Totals   Absent  Present 
 Test Positive  13 71 84 
 Test Negative  88 22 110 
 Totals  101 93 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.479381 0.407656 0.551937 
Sensitivity 0.763441 0.661921 0.842795 
Specificity 0.871287 0.786408 0.926978 
For any particular test result, the probability that it will be: 
Positive 0.43299 0.362756 0.505921 
Negative 0.56701 0.494079 0.637244 
For any particular positive test result, the probability that it is: 
True Positive 0.845238 0.746225 0.911827 
False Positive 0.154762 0.088173 0.253775 
For any particular negative test result, the probability that it is: 
True Negative 0.8 0.71072 0.867834 
False Negative 0.2 0.132166 0.28928 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 5.931348 3.526781 9.975354 
Negative [C] 0.271505 0.187918 0.392273 
Positive [W] 5.461538 3.285958 9.077537 
Negative [W] 0.25 0.171273 0.364915 
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For Group -2 Diseases 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Tue Oct 8 21:20:01 UTC+0100 2013) 
Values entered: 
 
Condition 
Totals   Absent  Present 
 Test Positive  22 88 110 
 Test Negative  71 13 84 
 Totals  93 101 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.520619 0.448063 0.592344 
Sensitivity 0.871287 0.786408 0.926978 
Specificity 0.763441 0.661921 0.842795 
For any particular test result, the probability that it will be: 
Positive 0.56701 0.494079 0.637244 
Negative 0.43299 0.362756 0.505921 
For any particular positive test result, the probability that it is: 
True Positive 0.8 0.71072 0.867834 
False Positive 0.2 0.132166 0.28928 
For any particular negative test result, the probability that it is: 
True Negative 0.845238 0.746225 0.911827 
False Negative 0.154762 0.088173 0.253775 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 3.683168 2.537168 5.3468 
Negative [C] 0.168596 0.100843 0.281868 
Positive [W] 4 2.721116 5.879941 
Negative [W] 0.183099 0.110608 0.303099 
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Third Phase 
 
Estimation of the Disease Groups by Testers 
Crosstabs   
 
Row variable (first classifier): A-1 
Column variable (second classifier): Disease group 
 
 1 2  
1 74 29  
2 19 72  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 75.26% 
Expected agreement = 49.87% 
Kappa = 0.506414 (se = 0.071415) 
95% confidence interval = 0.366442 to 0.646385 
z (for k = 0) = 7.091117 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0  
0 1  
Observed agreement = 75.26% 
Expected agreement = 49.87% 
Kappa = 0.506414 (se = 0.071415) 
95% confidence interval for kappa = 0.366442 to 0.646385 
z (for kw = 0) = 7.091117 
P < 0.0001 
 
Scott's pi 
Observed agreement = 75.26% 
Expected agreement = 50.01% 
Pi = 0.505102 
95% Donner-Eliasziw confidence interval = 0.374627 to 0.615961 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 2.083333  df = 1  P = 0.1489 
 
Symmetry (generalised McNemar) chi-square = 2.083333  df = 1  P = 0.1489 
 
 
Crosstabs   
 
Row variable (first classifier): B-1 
Column variable (second classifier): Disease group 
 
 1 2  
1 77 20  
2 16 81  
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General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 81.44% 
Expected agreement = 50% 
Kappa = 0.628866 (se = 0.071735) 
95% confidence interval = 0.488268 to 0.769463 
z (for k = 0) = 8.766546 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0  
0 1  
Observed agreement = 81.44% 
Expected agreement = 50% 
Kappa = 0.628866 (se = 0.071735) 
95% confidence interval for kappa = 0.488268 to 0.769463 
z (for kw = 0) = 8.766546 
P < 0.0001 
 
Scott's pi 
Observed agreement = 81.44% 
Expected agreement = 50.02% 
Pi = 0.628708 
95% Donner-Eliasziw confidence interval = 0.50743 to 0.725563 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 0.444444  df = 1  P = 0.505 
 
Symmetry (generalised McNemar) chi-square = 0.444444  df = 1  P = 0.505 
 
 
 
Crosstabs   
 
Row variable (first classifier): C-1 
Column variable (second classifier): Disease group 
 
 1 2  
1 71 15  
2 22 86  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 80.93% 
Expected agreement = 50.23% 
Kappa = 0.616765 (se = 0.071607) 
95% confidence interval = 0.476418 to 0.757111 
z (for k = 0) = 8.613205 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0  
0 1  
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Observed agreement = 80.93% 
Expected agreement = 50.23% 
Kappa = 0.616765 (se = 0.071607) 
95% confidence interval for kappa = 0.476418 to 0.757111 
z (for kw = 0) = 8.613205 
P < 0.0001 
 
Scott's pi 
Observed agreement = 80.93% 
Expected agreement = 50.3% 
Pi = 0.616263 
95% Donner-Eliasziw confidence interval = 0.493553 to 0.714938 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 1.324324  df = 1  P = 0.2498 
 
Symmetry (generalised McNemar) chi-square = 1.324324  df = 1  P = 0.2498 
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Third Phase: Disease Groups: Sensitivity, Specificity 
 
Rater A 
 
Group -1  
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 12:36:30 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  29 74 103 
 Test Negative  72 19 91 
 Totals  101 93 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.479381 0.407656 0.551937 
Sensitivity 0.795699 0.696916 0.86953 
Specificity 0.712871 0.612929 0.796359 
For any particular test result, the probability that it will be: 
Positive 0.530928 0.458238 0.602373 
Negative 0.469072 0.397627 0.541762 
For any particular positive test result, the probability that it is: 
True Positive 0.718447 0.619847 0.80048 
False Positive 0.281553 0.19952 0.380153 
For any particular negative test result, the probability that it is: 
True Negative 0.791209 0.690754 0.866568 
False Negative 0.208791 0.133432 0.309246 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 2.771227 2.004108 3.831979 
Negative [C] 0.286589 0.190403 0.431366 
Positive [W] 2.551724 1.832045 3.554114 
Negative [W] 0.263889 0.175895 0.395904 
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Rater A 
 
Group -2 
 
  
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 12:37:31 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  19 72 91 
 Test Negative  74 29 103 
 Totals  93 101 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.520619 0.448063 0.592344 
Sensitivity 0.712871 0.612929 0.796359 
Specificity 0.795699 0.696916 0.86953 
For any particular test result, the probability that it will be: 
Positive 0.469072 0.397627 0.541762 
Negative 0.530928 0.458238 0.602373 
For any particular positive test result, the probability that it is: 
True Positive 0.791209 0.690754 0.866568 
False Positive 0.208791 0.133432 0.309246 
For any particular negative test result, the probability that it is: 
True Negative 0.718447 0.619847 0.80048 
False Negative 0.281553 0.19952 0.380153 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 3.489317 2.293206 5.309309 
Negative [C] 0.360851 0.26395 0.493326 
Positive [W] 3.789474 2.50572 5.730933 
Negative [W] 0.391892 0.285727 0.537504 
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Rater B 
 
Group -1  
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 12:31:48 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  20 77 97 
 Test Negative  81 16 97 
 Totals  101 93 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.479381 0.407656 0.551937 
Sensitivity 0.827957 0.73263 0.895504 
Specificity 0.80198 0.708391 0.872071 
For any particular test result, the probability that it will be: 
Positive 0.5 0.427802 0.572198 
Negative 0.5 0.427802 0.572198 
For any particular positive test result, the probability that it is: 
True Positive 0.793814 0.697226 0.866626 
False Positive 0.206186 0.133374 0.302774 
For any particular negative test result, the probability that it is: 
True Negative 0.835052 0.742928 0.899927 
False Negative 0.164948 0.100073 0.257072 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 4.181183 2.7936 6.257979 
Negative [C] 0.214523 0.136698 0.336655 
Positive [W] 3.85 2.571895 5.763261 
Negative [W] 0.197531 0.125731 0.310333 
 
                                                                                                          Levent Bayam @00279526    
163 
 
Rater B 
 
Group -2  
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 12:34:40 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  16 81 97 
 Test Negative  77 20 97 
 Totals  93 101 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.520619 0.448063 0.592344 
Sensitivity 0.80198 0.708391 0.872071 
Specificity 0.827957 0.73263 0.895504 
For any particular test result, the probability that it will be: 
Positive 0.5 0.427802 0.572198 
Negative 0.5 0.427802 0.572198 
For any particular positive test result, the probability that it is: 
True Positive 0.835052 0.742928 0.899927 
False Positive 0.164948 0.100073 0.257072 
For any particular negative test result, the probability that it is: 
True Negative 0.793814 0.697226 0.866626 
False Negative 0.206186 0.133374 0.302774 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 4.66151 2.953754 7.35663 
Negative [C] 0.239167 0.160823 0.355675 
Positive [W] 5.0625 3.207366 7.990639 
Negative [W] 0.25974 0.174856 0.385833 
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Rater C 
 
Group -1 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 12:39:11 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  15 71 86 
 Test Negative  86 22 108 
 Totals  101 93 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.479381 0.407656 0.551937 
Sensitivity 0.763441 0.661921 0.842795 
Specificity 0.851485 0.763685 0.911754 
For any particular test result, the probability that it will be: 
Positive 0.443299 0.372682 0.516198 
Negative 0.556701 0.483802 0.627318 
For any particular positive test result, the probability that it is: 
True Positive 0.825581 0.725445 0.895931 
False Positive 0.174419 0.104069 0.274555 
For any particular negative test result, the probability that it is: 
True Negative 0.796296 0.705719 0.865311 
False Negative 0.203704 0.134689 0.294281 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 5.140502 3.17933 8.311423 
Negative [C] 0.277819 0.192189 0.401604 
Positive [W] 4.733333 2.958454 7.573025 
Negative [W] 0.255814 0.175375 0.373148 
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Rater C 
 
Group -2 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 12:40:02 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  22 86 108 
 Test Negative  71 15 86 
 Totals  93 101 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.520619 0.448063 0.592344 
Sensitivity 0.851485 0.763685 0.911754 
Specificity 0.763441 0.661921 0.842795 
For any particular test result, the probability that it will be: 
Positive 0.556701 0.483802 0.627318 
Negative 0.443299 0.372682 0.516198 
For any particular positive test result, the probability that it is: 
True Positive 0.796296 0.705719 0.865311 
False Positive 0.203704 0.134689 0.294281 
For any particular negative test result, the probability that it is: 
True Negative 0.825581 0.725445 0.895931 
False Negative 0.174419 0.104069 0.274555 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 3.59946 2.476137 5.23239 
Negative [C] 0.194534 0.121159 0.312344 
Positive [W] 3.909091 2.660233 5.74423 
Negative [W] 0.211268 0.132754 0.336216 
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Third Phase: Group Agreement between the Testers 
 
General agreement over all (2) categories with 3 raters per subject   
 
Cohen's kappa (Fleiss-Cuzick extension): 
 
Kappa = 0.697505 (se = 0.041451) 
z (for k = 0) = 16.827087 
P < 0.0001 
 
 
General agreement over all (2) categories with 3 raters per subject   
 
Cohen's kappa (Fleiss-Cuzick extension): 
 
Kappa = 0.697505 (se = 0.041451) 
z (for k = 0) = 16.827087 
P < 0.0001 
 
 
Crosstabs   
 
Row variable (first classifier): A-1 
Column variable (second classifier): B-1 
 
 1 2  
1 83 20  
2 14 77  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 82.47% 
Expected agreement = 50% 
Kappa = 0.649485 (se = 0.071658) 
95% confidence interval = 0.509037 to 0.789932 
z (for k = 0) = 9.063629 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0  
0 1  
Observed agreement = 82.47% 
Expected agreement = 50% 
Kappa = 0.649485 (se = 0.071658) 
95% confidence interval for kappa = 0.509037 to 0.789932 
z (for kw = 0) = 9.063629 
P < 0.0001 
 
Scott's pi 
Observed agreement = 82.47% 
Expected agreement = 50.05% 
Pi = 0.649149 
95% Donner-Eliasziw confidence interval = 0.529747 to 0.743323 
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Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 1.058824  df = 1  P = 0.3035 
 
Symmetry (generalised McNemar) chi-square = 1.058824  df = 1  P = 0.3035 
 
 
Crosstabs   
 
Row variable (first classifier): A-1 
Column variable (second classifier): C-1 
 
 1 2  
1 77 26  
2 9 82  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 81.96% 
Expected agreement = 49.65% 
Kappa = 0.641689 (se = 0.0707) 
95% confidence interval = 0.503119 to 0.780258 
z (for k = 0) = 9.076199 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0  
0 1  
Observed agreement = 81.96% 
Expected agreement = 49.65% 
Kappa = 0.641689 (se = 0.0707) 
95% confidence interval for kappa = 0.503119 to 0.780258 
z (for kw = 0) = 9.076199 
P < 0.0001 
 
Scott's pi 
Observed agreement = 81.96% 
Expected agreement = 50.03% 
Pi = 0.638935 
95% Donner-Eliasziw confidence interval = 0.518582 to 0.734464 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 8.257143  df = 1  P = 0.0041 
 
Symmetry (generalised McNemar) chi-square = 8.257143  df = 1  P = 0.0041 
 
 
Crosstabs   
 
Row variable (first classifier): B-1 
Column variable (second classifier): C-1 
 
 1 2  
1 82 15  
2 4 93  
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General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 90.21% 
Expected agreement = 50% 
Kappa = 0.804124 (se = 0.071333) 
95% confidence interval = 0.664314 to 0.943933 
z (for k = 0) = 11.272867 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0  
0 1  
Observed agreement = 90.21% 
Expected agreement = 50% 
Kappa = 0.804124 (se = 0.071333) 
95% confidence interval for kappa = 0.664314 to 0.943933 
z (for kw = 0) = 11.272867 
P < 0.0001 
 
Scott's pi 
Observed agreement = 90.21% 
Expected agreement = 50.16% 
Pi = 0.803492 
95% Donner-Eliasziw confidence interval = 0.703301 to 0.872387 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 6.368421  df = 1  P = 0.0116 
 
Symmetry (generalised McNemar) chi-square = 6.368421  df = 1  P = 0.0116 
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Third Phase: Estimation of Individual Shoulder Disorders by Testers 
Crosstabs   
 
Row variable (first classifier): Overall best Est-A 
Column variable (second classifier): Actual 
 
 1 2 3 4 5 6 7  
1 16 3 0 6 1 7 0  
2 7 42 0 1 2 5 0  
3 0 1 7 2 1 1 0  
4 4 8 0 16 1 5 2  
5 1 0 0 2 12 5 0  
6 1 3 0 1 5 23 0  
7 0 0 0 1 0 0 2  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 60.82% 
Expected agreement = 19.41% 
Kappa = 0.513913 (se = 0.033852) 
95% confidence interval = 0.447564 to 0.580261 
z (for k = 0) = 15.181235 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0.8333 0.6667 0.5 0.3333 0.1667 0  
0.8333 1 0.8333 0.6667 0.5 0.3333 0.1667  
0.6667 0.8333 1 0.8333 0.6667 0.5 0.3333  
0.5 0.6667 0.8333 1 0.8333 0.6667 0.5  
0.3333 0.5 0.6667 0.8333 1 0.8333 0.6667  
0.1667 0.3333 0.5 0.6667 0.8333 1 0.8333  
0 0.1667 0.3333 0.5 0.6667 0.8333 1  
Observed agreement = 84.02% 
Expected agreement = 65.09% 
Kappa = 0.542209 (se = 0.050451) 
95% confidence interval for kappa = 0.443326 to 0.641092 
z (for kw = 0) = 10.747145 
P < 0.0001 
 
Scott's pi 
Observed agreement = 60.82% 
Expected agreement = 19.58% 
Pi = 0.512853 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 11.975026  df = 6  P = 0.0625 
 
Symmetry (generalised McNemar) chi-square = 22.777778  df = 21  P = 0.3559 
 
 
Crosstabs   
 
Row variable (first classifier): Overall best Est-B 
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Column variable (second classifier): Actual 
 
 1 2 3 4 5 6 7  
1 21 8 0 5 3 4 0  
2 4 46 0 0 0 0 0  
3 0 1 3 0 0 0 0  
4 2 1 2 21 3 9 1  
5 1 0 1 2 7 6 0  
6 1 1 1 1 6 25 2  
7 0 0 0 0 3 2 1  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 63.92% 
Expected agreement = 19.39% 
Kappa = 0.552377 (se = 0.034078) 
95% confidence interval = 0.485585 to 0.619168 
z (for k = 0) = 16.209175 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0.8333 0.6667 0.5 0.3333 0.1667 0  
0.8333 1 0.8333 0.6667 0.5 0.3333 0.1667  
0.6667 0.8333 1 0.8333 0.6667 0.5 0.3333  
0.5 0.6667 0.8333 1 0.8333 0.6667 0.5  
0.3333 0.5 0.6667 0.8333 1 0.8333 0.6667  
0.1667 0.3333 0.5 0.6667 0.8333 1 0.8333  
0 0.1667 0.3333 0.5 0.6667 0.8333 1  
Observed agreement = 88.14% 
Expected agreement = 64% 
Kappa = 0.670669 (se = 0.051021) 
95% confidence interval for kappa = 0.570669 to 0.770669 
z (for kw = 0) = 13.14484 
P < 0.0001 
 
Scott's pi 
Observed agreement = 63.92% 
Expected agreement = 19.66% 
Pi = 0.550852 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 13.67632  df = 6  P = 0.0335 
 
Symmetry (generalised McNemar) chi-square = 23.019048  df = 21  P = 0.343 
 
 
Crosstabs   
 
Row variable (first classifier): overall best Est-C 
Column variable (second classifier): Actual 
 
 1 2 3 4 5 6 7  
1 16 3 0 3 1 5 0  
2 5 37 0 1 0 0 0  
3 2 3 5 3 1 1 0  
4 2 10 1 15 0 13 0  
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5 3 1 1 0 12 3 0  
6 0 3 0 4 1 24 0  
7 1 0 0 3 7 0 4  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 58.25% 
Expected agreement = 17.35% 
Kappa = 0.49484 (se = 0.031743) 
95% confidence interval = 0.432626 to 0.557055 
z (for k = 0) = 15.58912 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0.8333 0.6667 0.5 0.3333 0.1667 0  
0.8333 1 0.8333 0.6667 0.5 0.3333 0.1667  
0.6667 0.8333 1 0.8333 0.6667 0.5 0.3333  
0.5 0.6667 0.8333 1 0.8333 0.6667 0.5  
0.3333 0.5 0.6667 0.8333 1 0.8333 0.6667  
0.1667 0.3333 0.5 0.6667 0.8333 1 0.8333  
0 0.1667 0.3333 0.5 0.6667 0.8333 1  
Observed agreement = 84.02% 
Expected agreement = 63.95% 
Kappa = 0.556773 (se = 0.049343) 
95% confidence interval for kappa = 0.460063 to 0.653483 
z (for kw = 0) = 11.283786 
P < 0.0001 
 
Scott's pi 
Observed agreement = 58.25% 
Expected agreement = 17.83% 
Pi = 0.491876 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 31.465573  df = 6  P < 0.0001 
 
Symmetry (generalised McNemar) chi-square = 41.828342  df = 21  P = 0.0044 
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Third Phase: Sensitivity, Specificity of Estimations of Individual 
Disorders by the Testers  
Rater A Disease 1 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:34:14 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  17 16 33 
 Test Negative  148 13 161 
 Totals  165 29 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.149485 0.103959 0.209308 
Sensitivity 0.551724 0.359805 0.73046 
Specificity 0.89697 0.837675 0.937056 
For any particular test result, the probability that it will be: 
Positive 0.170103 0.121545 0.232086 
Negative 0.829897 0.767914 0.878455 
For any particular positive test result, the probability that it is: 
True Positive 0.484848 0.311668 0.661454 
False Positive 0.515152 0.338546 0.688332 
For any particular negative test result, the probability that it is: 
True Negative 0.919255 0.863043 0.954538 
False Negative 0.080745 0.045462 0.136957 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 5.35497 3.067823 9.347248 
Negative [C] 0.499767 0.333287 0.749404 
Positive [W] 0.941176 0.580668 1.525508 
Negative [W] 0.087838 0.052104 0.148079 
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Rater A 
 
Disease 2 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:36:26 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  15 42 57 
 Test Negative  122 15 137 
 Totals  137 57 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.293814 0.231852 0.364102 
Sensitivity 0.736842 0.600941 0.840633 
Specificity 0.890511 0.822942 0.935341 
For any particular test result, the probability that it will be: 
Positive 0.293814 0.231852 0.364102 
Negative 0.706186 0.635898 0.768148 
For any particular positive test result, the probability that it is: 
True Positive 0.736842 0.600941 0.840633 
False Positive 0.263158 0.159367 0.399059 
For any particular negative test result, the probability that it is: 
True Negative 0.890511 0.822942 0.935341 
False Negative 0.109489 0.064659 0.177058 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 6.729825 4.073196 11.119166 
Negative [C] 0.295513 0.191054 0.457086 
Positive [W] 2.8 1.765348 4.441052 
Negative [W] 0.122951 0.076132 0.198561 
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Rater A 
 
Disease 3 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:38:18 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  5 7 12 
 Test Negative  182 0 182 
 Totals  187 7 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.036082 0.015902 0.075935 
Sensitivity 1 0.560935 1 
Specificity 0.973262 0.935341 0.990115 
For any particular test result, the probability that it will be: 
Positive 0.061856 0.033836 0.108132 
Negative 0.938144 0.891868 0.966164 
For any particular positive test result, the probability that it is: 
True Positive 0.583333 0.285993 0.835007 
False Positive 0.416667 0.164993 0.714007 
For any particular negative test result, the probability that it is: 
True Negative 1 0.974235 1 
False Negative 0 0 0.025765 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 37.4 15.751688 88.800642 
Negative [C] 0 0 NaN 
Positive [W] 1.4 0.614945 3.187275 
Negative [W] 0 0 NaN 
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Rater A 
 
Disease 4 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:29:16 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  22 16 38 
 Test Negative  143 13 156 
 Totals  165 29 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.149485 0.103959 0.209308 
Sensitivity 0.551724 0.359805 0.73046 
Specificity 0.866667 0.802943 0.912755 
For any particular test result, the probability that it will be: 
Positive 0.195876 0.143908 0.260192 
Negative 0.804124 0.739808 0.856092 
For any particular positive test result, the probability that it is: 
True Positive 0.421053 0.267203 0.590555 
False Positive 0.578947 0.409445 0.732797 
For any particular negative test result, the probability that it is: 
True Negative 0.916667 0.85882 0.953062 
False Negative 0.083333 0.046938 0.14118 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 4.137931 2.4876 6.883129 
Negative [C] 0.517241 0.344781 0.775967 
Positive [W] 0.727273 0.458657 1.153205 
Negative [W] 0.090909 0.053961 0.153156 
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Rater A 
 
Disease 5 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:40:25 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  8 12 20 
 Test Negative  164 10 174 
 Totals  172 22 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.113402 0.073991 0.168673 
Sensitivity 0.545455 0.32674 0.749293 
Specificity 0.953488 0.907225 0.978213 
For any particular test result, the probability that it will be: 
Positive 0.103093 0.065661 0.156842 
Negative 0.896907 0.843158 0.934339 
For any particular positive test result, the probability that it is: 
True Positive 0.6 0.364117 0.800229 
False Positive 0.4 0.199771 0.635883 
For any particular negative test result, the probability that it is: 
True Negative 0.942529 0.893896 0.970531 
False Negative 0.057471 0.029469 0.106104 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 11.727273 5.3933 25.499959 
Negative [C] 0.476718 0.301455 0.753877 
Positive [W] 1.5 0.786914 2.859272 
Negative [W] 0.060976 0.033384 0.111373 
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Rater A 
 
Disease 6 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:42:02 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  10 23 33 
 Test Negative  128 23 151 
 Totals  138 46 184 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.25 0.190538 0.320126 
Sensitivity 0.5 0.351188 0.648812 
Specificity 0.927536 0.867314 0.962754 
For any particular test result, the probability that it will be: 
Positive 0.179348 0.128308 0.244134 
Negative 0.820652 0.755866 0.871692 
For any particular positive test result, the probability that it is: 
True Positive 0.69697 0.511269 0.837871 
False Positive 0.30303 0.162129 0.488731 
For any particular negative test result, the probability that it is: 
True Negative 0.847682 0.778094 0.899045 
False Negative 0.152318 0.100955 0.221906 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 6.9 3.554925 13.392686 
Negative [C] 0.539063 0.403325 0.720483 
Positive [W] 2.3 1.308243 4.043591 
Negative [W] 0.179688 0.123053 0.262387 
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Rater A 
 
Disease 7 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:43:09 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  1 2 3 
 Test Negative  189 2 191 
 Totals  190 4 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.020619 0.006625 0.055381 
Sensitivity 0.5 0.091899 0.908101 
Specificity 0.994737 0.966531 0.999725 
For any particular test result, the probability that it will be: 
Positive 0.015464 0.004002 0.048173 
Negative 0.984536 0.951827 0.995998 
For any particular positive test result, the probability that it is: 
True Positive 0.666667 0.125335 0.982347 
False Positive 0.333333 0.017653 0.874665 
For any particular negative test result, the probability that it is: 
True Negative 0.989529 0.958688 0.998184 
False Negative 0.010471 0.001816 0.041312 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 95 10.667408 846.034936 
Negative [C] 0.502646 0.188642 1.339323 
Positive [W] 2 0.334191 11.969212 
Negative [W] 0.010582 0.002666 0.042009 
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Rater B 
 
Disease 1 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:46:20 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  6 21 27 
 Test Negative  147 20 167 
 Totals  153 41 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.21134 0.157503 0.276882 
Sensitivity 0.512195 0.353655 0.668486 
Specificity 0.960784 0.912816 0.983959 
For any particular test result, the probability that it will be: 
Positive 0.139175 0.095283 0.197807 
Negative 0.860825 0.802193 0.904717 
For any particular positive test result, the probability that it is: 
True Positive 0.777778 0.572664 0.906244 
False Positive 0.222222 0.093756 0.427336 
For any particular negative test result, the probability that it is: 
True Negative 0.88024 0.81883 0.923537 
False Negative 0.11976 0.076463 0.18117 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 13.060976 5.642708 30.231774 
Negative [C] 0.507715 0.37083 0.695129 
Positive [W] 3.5 1.68011 7.291191 
Negative [W] 0.136054 0.090042 0.205579 
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Rater B 
 
Disease 2 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:47:37 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  4 46 50 
 Test Negative  133 11 144 
 Totals  137 57 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.293814 0.231852 0.364102 
Sensitivity 0.807018 0.676833 0.895278 
Specificity 0.970803 0.922337 0.990606 
For any particular test result, the probability that it will be: 
Positive 0.257732 0.198976 0.326285 
Negative 0.742268 0.673715 0.801024 
For any particular positive test result, the probability that it is: 
True Positive 0.92 0.7989 0.97406 
False Positive 0.08 0.02594 0.2011 
For any particular negative test result, the probability that it is: 
True Negative 0.923611 0.864183 0.959341 
False Negative 0.076389 0.040659 0.135817 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 27.640351 10.437441 73.196966 
Negative [C] 0.198786 0.116854 0.338166 
Positive [W] 11.5 4.476476 29.543326 
Negative [W] 0.082707 0.046817 0.14611 
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Rater B 
 
Disease 3 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:48:34 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  1 3 4 
 Test Negative  186 4 190 
 Totals  187 7 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.036082 0.015902 0.075935 
Sensitivity 0.428571 0.118083 0.797628 
Specificity 0.994652 0.966006 0.999721 
For any particular test result, the probability that it will be: 
Positive 0.020619 0.006625 0.055381 
Negative 0.979381 0.944619 0.993375 
For any particular positive test result, the probability that it is: 
True Positive 0.75 0.219427 0.986809 
False Positive 0.25 0.013191 0.780573 
For any particular negative test result, the probability that it is: 
True Negative 0.978947 0.943481 0.993235 
False Negative 0.021053 0.006765 0.056519 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 80.142857 9.488946 676.879998 
Negative [C] 0.574501 0.302444 1.091279 
Positive [W] 3 0.501286 17.953818 
Negative [W] 0.021505 0.008154 0.05672 
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Rater B 
 
Disease 4 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:50:27 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  19 21 40 
 Test Negative  146 8 154 
 Totals  165 29 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.149485 0.103959 0.209308 
Sensitivity 0.724138 0.525149 0.865541 
Specificity 0.884848 0.823669 0.927457 
For any particular test result, the probability that it will be: 
Positive 0.206186 0.152958 0.271332 
Negative 0.793814 0.728668 0.847042 
For any particular positive test result, the probability that it is: 
True Positive 0.525 0.363442 0.681838 
False Positive 0.475 0.318162 0.636558 
For any particular negative test result, the probability that it is: 
True Negative 0.948052 0.896746 0.975645 
False Negative 0.051948 0.024355 0.103254 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 6.288566 3.895475 10.151797 
Negative [C] 0.311762 0.172607 0.563102 
Positive [W] 1.105263 0.712287 1.715048 
Negative [W] 0.054795 0.027888 0.107662 
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Rater B 
 
Disease 5 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:51:55 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  10 7 17 
 Test Negative  162 15 177 
 Totals  172 22 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.113402 0.073991 0.168673 
Sensitivity 0.318182 0.147343 0.548842 
Specificity 0.94186 0.892701 0.970185 
For any particular test result, the probability that it will be: 
Positive 0.087629 0.053411 0.138867 
Negative 0.912371 0.861133 0.946589 
For any particular positive test result, the probability that it is: 
True Positive 0.411765 0.194279 0.665465 
False Positive 0.588235 0.334535 0.805721 
For any particular negative test result, the probability that it is: 
True Negative 0.915254 0.861549 0.950143 
False Negative 0.084746 0.049857 0.138451 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 5.472727 2.32074 12.905687 
Negative [C] 0.723906 0.543757 0.963739 
Positive [W] 0.7 0.349865 1.40054 
Negative [W] 0.092593 0.056999 0.150412 
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Rater B 
 
Disease 6 
 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:53:37 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  12 25 37 
 Test Negative  136 21 157 
 Totals  148 46 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.237113 0.180425 0.304445 
Sensitivity 0.543478 0.391558 0.688211 
Specificity 0.918919 0.859566 0.955513 
For any particular test result, the probability that it will be: 
Positive 0.190722 0.139404 0.2546 
Negative 0.809278 0.7454 0.860596 
For any particular positive test result, the probability that it is: 
True Positive 0.675676 0.501055 0.814449 
False Positive 0.324324 0.185551 0.498945 
For any particular negative test result, the probability that it is: 
True Negative 0.866242 0.800554 0.913416 
False Negative 0.133758 0.086584 0.199446 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 6.702899 3.665471 12.257319 
Negative [C] 0.496803 0.362028 0.681752 
Positive [W] 2.083333 1.243698 3.489817 
Negative [W] 0.154412 0.103506 0.230354 
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Rater B 
 
Disease 7 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:54:40 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  5 1 6 
 Test Negative  185 3 188 
 Totals  190 4 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.020619 0.006625 0.055381 
Sensitivity 0.25 0.013191 0.780573 
Specificity 0.973684 0.936336 0.990272 
For any particular test result, the probability that it will be: 
Positive 0.030928 0.012634 0.069224 
Negative 0.969072 0.930776 0.987366 
For any particular positive test result, the probability that it is: 
True Positive 0.166667 0.008762 0.635177 
False Positive 0.833333 0.364823 0.991238 
For any particular negative test result, the probability that it is: 
True Negative 0.984043 0.950325 0.99587 
False Negative 0.015957 0.00413 0.049675 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 9.5 1.413768 63.836516 
Negative [C] 0.77027 0.437323 1.356702 
Positive [W] 0.2 0.032256 1.240092 
Negative [W] 0.016216 0.005277 0.049834 
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Rater C 
 
Disease 1 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:57:25 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  12 16 28 
 Test Negative  153 13 166 
 Totals  165 29 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.149485 0.103959 0.209308 
Sensitivity 0.551724 0.359805 0.73046 
Specificity 0.927273 0.873527 0.960149 
For any particular test result, the probability that it will be: 
Positive 0.14433 0.099611 0.203567 
Negative 0.85567 0.796433 0.900389 
For any particular positive test result, the probability that it is: 
True Positive 0.571429 0.374319 0.74973 
False Positive 0.428571 0.25027 0.625681 
For any particular negative test result, the probability that it is: 
True Negative 0.921687 0.867021 0.955924 
False Negative 0.078313 0.044076 0.132979 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 7.586207 4.016279 14.329319 
Negative [C] 0.483435 0.322535 0.7246 
Positive [W] 1.333333 0.781187 2.275739 
Negative [W] 0.084967 0.05037 0.143329 
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Rater C 
 
Disease 2 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 10:58:59 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  6 37 43 
 Test Negative  131 20 151 
 Totals  137 57 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.293814 0.231852 0.364102 
Sensitivity 0.649123 0.510578 0.76755 
Specificity 0.956204 0.902995 0.982073 
For any particular test result, the probability that it will be: 
Positive 0.221649 0.166634 0.287944 
Negative 0.778351 0.712056 0.833366 
For any particular positive test result, the probability that it is: 
True Positive 0.860465 0.713734 0.941972 
False Positive 0.139535 0.058028 0.286266 
For any particular negative test result, the probability that it is: 
True Negative 0.86755 0.800498 0.915277 
False Negative 0.13245 0.084723 0.199502 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 14.821637 6.624087 33.163958 
Negative [C] 0.366948 0.257615 0.522682 
Positive [W] 6.166667 2.907324 13.079991 
Negative [W] 0.152672 0.101302 0.230092 
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Rater C 
 
Disease 3 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 11:00:15 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  10 5 15 
 Test Negative  177 2 179 
 Totals  187 7 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.036082 0.015902 0.075935 
Sensitivity 0.714286 0.302561 0.948876 
Specificity 0.946524 0.901055 0.972597 
For any particular test result, the probability that it will be: 
Positive 0.07732 0.045437 0.126705 
Negative 0.92268 0.873295 0.954563 
For any particular positive test result, the probability that it is: 
True Positive 0.333333 0.129878 0.613134 
False Positive 0.666667 0.386866 0.870122 
For any particular negative test result, the probability that it is: 
True Negative 0.988827 0.955983 0.998062 
False Negative 0.011173 0.001938 0.044017 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 13.357143 6.224126 28.664791 
Negative [C] 0.301856 0.093509 0.974421 
Positive [W] 0.5 0.224631 1.112938 
Negative [W] 0.011299 0.002848 0.044836 
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Rater C 
 
Disease 4 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 11:05:46 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  26 15 41 
 Test Negative  139 14 153 
 Totals  165 29 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.149485 0.103959 0.209308 
Sensitivity 0.517241 0.328996 0.701094 
Specificity 0.842424 0.775754 0.892682 
For any particular test result, the probability that it will be: 
Positive 0.21134 0.157503 0.276882 
Negative 0.78866 0.723118 0.842497 
For any particular positive test result, the probability that it is: 
True Positive 0.365854 0.225698 0.530805 
False Positive 0.634146 0.469195 0.774302 
For any particular negative test result, the probability that it is: 
True Negative 0.908497 0.848403 0.9472 
False Negative 0.091503 0.0528 0.151597 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 3.282493 1.994728 5.401619 
Negative [C] 0.573059 0.392304 0.837097 
Positive [W] 0.576923 0.362295 0.918698 
Negative [W] 0.100719 0.061055 0.166153 
 
 
                                                                                                          Levent Bayam @00279526    
190 
 
 
Rater C 
 
Disease 5 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 11:07:21 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  8 12 20 
 Test Negative  164 10 174 
 Totals  172 22 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.113402 0.073991 0.168673 
Sensitivity 0.545455 0.32674 0.749293 
Specificity 0.953488 0.907225 0.978213 
For any particular test result, the probability that it will be: 
Positive 0.103093 0.065661 0.156842 
Negative 0.896907 0.843158 0.934339 
For any particular positive test result, the probability that it is: 
True Positive 0.6 0.364117 0.800229 
False Positive 0.4 0.199771 0.635883 
For any particular negative test result, the probability that it is: 
True Negative 0.942529 0.893896 0.970531 
False Negative 0.057471 0.029469 0.106104 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 11.727273 5.3933 25.499959 
Negative [C] 0.476718 0.301455 0.753877 
Positive [W] 1.5 0.786914 2.859272 
Negative [W] 0.060976 0.033384 0.111373 
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Rater C 
 
Disease 6 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 11:08:40 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  8 24 32 
 Test Negative  140 22 162 
 Totals  148 46 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.237113 0.180425 0.304445 
Sensitivity 0.521739 0.371252 0.668633 
Specificity 0.945946 0.892707 0.974649 
For any particular test result, the probability that it will be: 
Positive 0.164948 0.117121 0.226418 
Negative 0.835052 0.773582 0.882879 
For any particular positive test result, the probability that it is: 
True Positive 0.75 0.562496 0.878729 
False Positive 0.25 0.121271 0.437504 
For any particular negative test result, the probability that it is: 
True Negative 0.864198 0.799452 0.911107 
False Negative 0.135802 0.088893 0.200548 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 9.652174 4.658251 19.999882 
Negative [C] 0.50559 0.373583 0.684243 
Positive [W] 3 1.593667 5.647351 
Negative [W] 0.157143 0.106357 0.23218 
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Rater C 
 
Disease 7 
 
 
VassarStats Printable Report: 
From an Observed Sample: Estimates of Population Prevalence, 
Sensitivity, Specificity, Predictive Values, and likelihood Ratios 
Wed Nov 20 11:09:40 UTC 2013)  
Values entered: 
 Condition 
Totals   Absent  Present 
 Test Positive  11 4 15 
 Test Negative  179 0 179 
 Totals  190 4 194 
 
Estimated 
Value 
95% Confidence Interval 
 Lower Limit Upper Limit 
Prevalence 0.020619 0.006625 0.055381 
Sensitivity 1 0.395774 1 
Specificity 0.942105 0.896084 0.969275 
For any particular test result, the probability that it will be: 
Positive 0.07732 0.045437 0.126705 
Negative 0.92268 0.873295 0.954563 
For any particular positive test result, the probability that it is: 
True Positive 0.266667 0.089136 0.551675 
False Positive 0.733333 0.448325 0.910864 
For any particular negative test result, the probability that it is: 
True Negative 1 0.973813 1 
False Negative 0 0 0.026187 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 17.272727 9.733175 30.6526 
Negative [C] 0 0 NaN 
Positive [W] 0.363636 0.148887 0.888133 
Negative [W] 0 0 NaN 
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Third Phase: Agreement of Estimations of Individual Shoulder 
Disorders Between the Testers 
General agreement over all (7) categories with 2 to 3 (median 3) raters per subject 
  
 
Cohen's kappa (Landis-Koch extension): 
 
Response Kappa se z(for k=0) Probability 
1 0.772336 * * * 
2 0.730965 * * * 
3 0.624838 * * * 
4 0.655137 * * * 
5 0.67323 * * * 
6 0.772131 * * * 
7 0.527159 * * * 
 
Combined (Fleiss-Nee-Landis test): 
 
Kappa = 0.710313 (se = *) 
z (for k = 0) = * 
* number of ratings per subject not constant, so tests do not apply 
 
 
Crosstabs   
 
Row variable (first classifier): A-1 
Column variable (second classifier): B-1 
 
 1 2 3 4 5 6 7  
1 33 1 0 1 0 0 0  
2 5 41 0 4 1 1 0  
3 1 0 7 1 1 0 0  
4 1 0 0 41 0 2 0  
5 0 0 0 1 15 0 0  
6 1 0 0 0 1 30 0  
7 1 0 0 0 0 0 4  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 88.14% 
Expected agreement = 19.13% 
Kappa = 0.853397 (se = 0.034009) 
95% confidence interval = 0.786741 to 0.920054 
z (for k = 0) = 25.093316 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0.8333 0.6667 0.5 0.3333 0.1667 0  
0.8333 1 0.8333 0.6667 0.5 0.3333 0.1667  
0.6667 0.8333 1 0.8333 0.6667 0.5 0.3333  
0.5 0.6667 0.8333 1 0.8333 0.6667 0.5  
0.3333 0.5 0.6667 0.8333 1 0.8333 0.6667  
0.1667 0.3333 0.5 0.6667 0.8333 1 0.8333  
0 0.1667 0.3333 0.5 0.6667 0.8333 1  
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Observed agreement = 95.79% 
Expected agreement = 65.54% 
Kappa = 0.877846 (se = 0.049453) 
95% confidence interval for kappa = 0.78092 to 0.974773 
z (for kw = 0) = 17.751098 
P < 0.0001 
 
Scott's pi 
Observed agreement = 88.14% 
Expected agreement = 19.25% 
Pi = 0.85318 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 12.3539  df = 6  P = 0.0545 
 
Symmetry (generalised McNemar) chi-square = 17.666667  df = 21  P = 0.67 
 
 
Crosstabs   
 
Row variable (first classifier): A-1 
Column variable (second classifier): C-1 
 
 1 2 3 4 5 6 7  
1 28 1 0 2 0 0 0  
2 0 37 0 10 3 0 1  
3 0 0 15 1 0 0 1  
4 1 2 0 30 0 4 4  
5 0 0 0 0 12 1 0  
6 2 0 0 1 0 32 0  
7 0 0 0 0 0 0 6  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 82.47% 
Expected agreement = 17.59% 
Kappa = 0.787322 (se = 0.032308) 
95% confidence interval = 0.724 to 0.850644 
z (for k = 0) = 24.369486 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0.8333 0.6667 0.5 0.3333 0.1667 0  
0.8333 1 0.8333 0.6667 0.5 0.3333 0.1667  
0.6667 0.8333 1 0.8333 0.6667 0.5 0.3333  
0.5 0.6667 0.8333 1 0.8333 0.6667 0.5  
0.3333 0.5 0.6667 0.8333 1 0.8333 0.6667  
0.1667 0.3333 0.5 0.6667 0.8333 1 0.8333  
0 0.1667 0.3333 0.5 0.6667 0.8333 1  
Observed agreement = 92.61% 
Expected agreement = 64.67% 
Kappa = 0.790864 (se = 0.048198) 
95% confidence interval for kappa = 0.696399 to 0.88533 
z (for kw = 0) = 16.408795 
P < 0.0001 
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Scott's pi 
Observed agreement = 82.47% 
Expected agreement = 17.71% 
Pi = 0.787016 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
 
Marginal homogeneity (Maxwell) chi-square = 13.160963  df = 6  P = 0.0405 
 
Symmetry (generalised McNemar) chi-square = 21.466667  df = 21  P = 0.4308 
 
 
Crosstabs   
 
Row variable (first classifier): B-1 
Column variable (second classifier): C-1 
 
 1 2 3 4 5 6 7  
1 33 1 1 2 1 1 0  
2 0 41 0 0 0 0 0  
3 0 0 7 0 0 0 0  
4 1 0 0 41 0 1 0  
5 0 0 1 0 13 1 0  
6 1 0 0 0 1 41 0  
7 0 0 0 0 0 0 5  
 
 
General agreement over all categories (2 raters)   
 
Cohen's kappa (unweighted) 
Observed agreement = 93.78% 
Expected agreement = 19.17% 
Kappa = 0.923077 (se = 0.034306) 
95% confidence interval = 0.855838 to 0.990316 
z (for k = 0) = 26.906949 
P < 0.0001 
 
Cohen's kappa (weighted by 1-abs(i-j)/(1-k)) 
ratings weighted by: 
1 0.8333 0.6667 0.5 0.3333 0.1667 0  
0.8333 1 0.8333 0.6667 0.5 0.3333 0.1667  
0.6667 0.8333 1 0.8333 0.6667 0.5 0.3333  
0.5 0.6667 0.8333 1 0.8333 0.6667 0.5  
0.3333 0.5 0.6667 0.8333 1 0.8333 0.6667  
0.1667 0.3333 0.5 0.6667 0.8333 1 0.8333  
0 0.1667 0.3333 0.5 0.6667 0.8333 1  
Observed agreement = 97.24% 
Expected agreement = 64.07% 
Kappa = 0.92309 (se = 0.050582) 
95% confidence interval for kappa = 0.823952 to 1.022228 
z (for kw = 0) = 18.249539 
P < 0.0001 
 
Scott's pi 
Observed agreement = 93.78% 
Expected agreement = 19.19% 
Pi = 0.923063 
 
Disagreement over any category and asymmetry of disagreement (2 raters) 
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Marginal homogeneity (Maxwell) chi-square = 12  df = 6  P = 0.062 
 
Symmetry (generalised McNemar) chi-square = 5.333333  df = 21  P = 0.9998 
 
 
 
 
 
 
 
 
